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ABSTRACT OF THE DISSERTATION 
 
RNA Polymerase Binding Protein A (RbpA) Regulation of Mycobacteria Transcription and 
Sensitivity to Fidaxomicin 
by 
Jerome Daniel Prusa 
Doctor of Philosophy in Biology and Biomedical Sciences 
Program in Molecular Microbiology and Microbial Pathogenesis 
Washington University in St. Louis, 2021 
Professor Christina L. Stallings  Ph.D, Chair 
Mycobacterium tuberculosis is the causative agent of the disease tuberculosis (TB) and 
remains one of the deadliest microorganisms on the planet. The effort to eradicate M. 
tuberculosis would benefit from the development of novel therapeutics, which requires a detailed 
understanding of M. tuberculosis physiology. Like all living organisms, M. tuberculosis gene 
expression requires transcription. Transcription in the phylum Actinobacteria, which includes 
mycobacteria, is unique because it includes RNA Polymerase Binding Protein A (RbpA) that is 




 RbpA increases the housekeeping A and housekeeping like B interactions with the 
RNA polymerase (RNAP) and can increase transcription by both A and B bound RNAPs in 
vitro, suggesting that RbpA activates M. tuberculosis transcription. During transcription 
initiation, the equilibrium between the melted and unmelted promoter conformations is a 
common regulatory target. RbpA stabilizes the melted DNA conformation called the RNA 
polymerase open promoter complex (RPo). Structural studies revealed that RbpA is comprised of 
four structural domains including the N-terminal tail (NTT), core domain (CD), basic linker (BL) 
and sigma interaction domain (SID). RbpA BL interacts with the DNA phosphate backbone of 
the non-template strand while the SID mediates RbpA’s interaction with σA and σB. The 
activities of both the BL and SID are important for RbpA RPo stabilizing activity in vitro. Using 
a panel of RbpA point mutants and RbpA domain truncation mutants, I further characterized the 
activities of RbpA’s four structural domains in vitro and in vivo. The activities of all four 
domains are required for M. tuberculosis growth while only the BL and SID are required for M. 
smegmatis growth. RNA-sequencing analysis revealed that RbpA activates transcription of some 
genes while repressing the transcription of other genes, and the activities of the BL/SID and 
NTT/CD affect transcription of two distinct gene subsets. We determined that the SID is 
necessary and sufficient for RbpA interaction with both the A and B bound RNAPs and 
weakening RbpA’s interaction with the RNAP decreases RbpA protein levels in M. smegmatis. 
In vitro analysis done in collaboration with the Galburt lab revealed that the BL and SID are 
required for RbpA’s RPo stabilizing activity while the NTT and CD antagonize RbpA RPo 
stabilizing activity. 
Structural studies show that the NTT and CD are positioned near multiple RNAP-A 
holoenzyme functional domains, suggesting that the RbpA NTT and CD could have a number of 
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effects on RNAP activity. However, these studies did not identify which contacts between the 
NTT or CD and the RNAP mediate the antagonism of RPo stability that we observed in our 
studies. In addition, structural studies predict that the RbpA NTT contributes contacts to the 
binding site for the antibiotic fidaxomicin (Fdx) on the RNAP. Deletion of the NTT results in a 
decrease in M. smegmatis sensitivity to Fdx, but whether this is caused by a loss of contacts with 
Fdx was unknown. Using a panel of rbpA mutants with single amino acid substitutions replacing 
conserved residues within the NTT, I probed what RbpA NTT residues are involved in 
regulating Fdx activity and RPo stability. We identify multiple residues in the NTT along with 
other RbpA domains that contribute to Fdx activity in vivo. We also identify RbpA NTT residues 
that contribute to antagonism of RbpA-mediated stabilization of RPo and link this antagonism to 
increased full length transcript production. 
 In work characterizing the role of RbpA’s interaction with B I determined that the loss 
of RbpA BL or SID activities alters sigB from its typical status as a non-essential gene to a 
synthetically essential gene. RNA-sequencing analysis of M. smegmatis with a sigB deletion 
(sigB) shows that sigB regulates a cohort of transcripts that if translated encode short and 
highly charged proteins. In addition, the subset of transcripts differentially expressed in M. 
smegmatis sigB shares little overlap with the gene subset differentially expressed in M. 
smegmatis expressing rbpA with a point mutation in the SID that weakens RbpA interaction with 
both A and B, suggesting that RbpA-independent B regulation occurs during logarithmic 
growth. 
 My thesis work has improved our understanding of RbpA regulation of mycobacteria 
transcription and RbpA’s role in fidaxomicin activity. This work shows that RbpA regulates 
transcription through novel mechanisms, shedding new light on the similarities and differences 
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between the Actinobacteria and E. coli paradigms of bacterial transcription. Furthermore, the 
design of future therapeutics might benefit from this interrogation of RbpA activities and how 










































































The Bacterial RNA Polymerase 
For all cellular organisms, transcription is carried out by a DNA dependent RNA 
polymerase (RNAP) that links nucleotide triphosphates together through a phosphodiester bond 
1. The structure of archaeal, bacterial and eukaryotic RNAPs are similar in resembling a crab 
claw with two mobile pincer domains that open and close around a region called the primary 
channel 2–4. At the base of the primary channel is Mg2+ required for catalysis of the 
phosphodiester bond. In addition to the primary channel, which accommodates DNA, RNAPs of 
all living organisms contain two additional channels including the secondary channel where 
substrate NTPs enter the RNAP, and the RNA exit channel where an elongating RNA transcript 
leaves the RNAP. 
The core bacterial RNAP (bRNAP) consists of five protein subunits including two 
identical  subunits,  , ’ and , discovered by Richard Burgess when he purified the E. coli 
core RNAP (Figure 1)5. The bRNAP is a combination of highly conserved regions that are 
shared among all bRNAPs and regions that are unique to the RNAPs of certain subsets of 
bacteria 6,7. Most of the highly conserved regions of the RNAP are located within the interior of 
the core RNAP and most of these regions are required for either catalysis of phosphodiester bond 
formation or interactions with DNA or RNA. These conserved bRNAP core regions among 
others include the ’ clamp that makes up one pincer of the crab claw, the  protrusion and  
lobe that together make up the second pincer of the crab claw 8–10, the bridge helix and trigger 
loop that mediate NTP addition to the growing RNA 11,12, and the base of the primary channel 
containing the NADFDGD motif that constitutes the active center of the RNAP 13,14. The highly 
conserved regions of the RNAP are connected to one another by lineage specific insertions that 
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in some cases are hundreds of amino acids in length and generally reside on the exterior of the 
bacterial RNAP 6,7. The function of these lineage specific insertions is mostly unknown.  
In addition to the core RNAP all bacteria have at least one housekeeping  factor that 
binds to the RNAP to form the holoenzyme and is responsible for the expression of essential 
genes 15. The number of  factors encoded by a bacterium varies widely from a single  factor 
such as for Mycoplasma to Plesiocytis pacifica, which is the current record holder, encoding at 
least 118  factors (collected from MiST 3.0 https://mistdb.com) 16. There are two groups of  
factors in bacteria including the 70-like group and the 54-like group. The majority of bacterial 
transcription research has focused on the 70-like group, which are able to melt DNA in an ATP-
independent manner unlike the 54-like group that require ATP for DNA melting 17. Despite 
being functionally homologous with both  factor groups being capable of initiating 
transcription, the 70-like and 54-like groups are structurally distinct from one another and 
initiate transcription through distinct mechanisms. M. tuberculosis encodes 13 70-like  factors 
and zero 54-like  factors and therefore from this point on any mention of  factors is in 
reference to 70-like  factors 18.  
Structurally,  factors are comprised of a variable number of globular domains that are 
connected to one another by flexible linker domains. There are four types of 70-like  factors 
organized by domain complexity (Figure 2) 19. Type I  factors are the most complex and 
include three highly conserved globular domains, domains 2, 3, and 4, an unstructured and 
poorly conserved N-terminal domain 1.1 and a non-conserved domain that connects region 1.1 
and region 2. Type II  factors are structurally similar to type I  factors except the type II  
factors lack domain 1.1 20. Type III  factors lack both domain 1.1 and the non-conserved 
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domain, while type IV  factors are comprised of only domains 2 and 4 20,21. In addition to these 
five domains used to categorize 70-like  factors into types I - IV, type I  factors’ domains 2 
and 3  are further divided into domains 2.1 – 2.4 and domains 3.0 – 3.2, while both type I and 
type II  factors have an additional region 1.2 located between domain 1.1 and the non-
conserved domain in the type I  factors or located at the N-terminus of type II  factors (Figure 
2). The conserved globular domains 2, 3 and 4 are important for allowing  to bind the RNAP or 
DNA in a similar manner across bacterial species 8–10. The function of the non-conserved domain 
is not yet known but it may provide species specific binding sites for transcription factors 22. The 
functions performed by region 1.1 continues to grow. The functions of region 1.1 include 
preventing free  binding to DNA by interacting with the  C-terminus, which maintains a 
compact  structure that masks ’s DNA binding domains 23,24, preventing non-specific 
holoenzyme interaction with DNA by occupying the holoenzyme primary channel as a DNA-
mimic 25,26 and suppressing E. coli rRNA expression during the stringent response 27. Region 3.2 
is a conserved unstructured linker in type I  factors that connects the globular portion of domain 
3 and domain 4. Like region 1.1, many different functions have been described for region 3.2 
including NTP substrate binding via region 3.2 interactions with the DNA template strand 28,29, 
regulating the transition from transcription initiation to transcription elongation 29,30 and 
contributing to E. coli’s stringent response 31. 
Upon core RNAP binding,  undergoes a conformational change that repositions  to 
span the length of the RNAP, allowing multiple interactions between  and the core RNAP and 
correctly positions ’s DNA binding regions for sequence specific DNA interactions 32–34. The 
extra domains in type I housekeeping 70 mediates more interactions between type I  factors 
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and core RNAP, which likely explains why type I  factors have the highest affinity for core 
RNAP 35. However, type I - IV  factors all bind to conserved core RNAP structures in a similar 
manner that involves  region 2 binding to the RNAP ’ coiled coil and  region 4 binding to the 
 flap tip helix 36–40.  
The Steps of Bacterial Transcription 
Bacterial Promoter Composition and RNAP Holoenzyme Promoter Recognition 
 The holoenzyme interacts with DNA sequence elements that are collectively termed the 
promoter. Bacteria holoenzymes utilize at least six DNA promoter sequence elements to bind to 
DNA and initiate transcription. The six promoter sequence elements that have been discovered 
thus far include the -10 element, -35 element, extended -10 element, discriminator region, UP 
element and the core recognition element (CRE) (Figure 3).  
 The -10 element was the first promoter sequence element discovered independently by 
both Pribnow and Schaller et al 41,42. The consensus -10 element in E. coli is 5’ – TATAAT – 3’ 
and most commonly occupies positions -12 to -7 relative to the +1 transcription start site (TSS). 
A highly conserved group of aromatic residues in region 2 of 70 interact with the -10 element 
8,19.   
 The -35 element was discovered shortly after the -10 element and was determined to have 
the consensus sequence 5’ – TTGACA – 3’ in E. coli 43,44. Initial holoenzyme recognition of the 
promoter occurs at the upstream sequence elements including the -35 element 45. A helix-turn-
helix motif in 70 region 4 fits into the minor groove of the -35 element, which stabilizes the 
RNAP-DNA interaction and positions the holoenzyme for subsequent interactions with 
downstream promoter sequence elements 46.  
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 The discriminator region was the third sequence element to be discovered through 
characterization of promoters regulated by (p)ppGpp during the stringent response in E. coli 47. 
The ‘stringent’ promoters or those that are repressed during the stringent response were found to 
have an enrichment of cytosine at positions -5 to +1 but a consensus discriminator sequence was 
not defined. Analyses almost two and half decades after the initial description of the 
discriminator region defined the consensus discriminator region in E. coli as 5’ – GGGA – 3’ at 
positions -6 to -3 on the non-template DNA strand 48,49. The discriminator region interacts with 
70 region 1.2 8. 
 The extended -10 element is located at positions -15 and -14 directly upstream of the -10 
element. In E. coli, the consensus extended -10 element is -15T and -14G. The extended -10 
element was identified through the discovery that certain sequences immediately upstream of the 
-10 element could compensate for loss of holoenzyme activity in the absence of the -35 element 
50,51. Regions 3.0 and 3.1 of 70 interact with the extended -10 element 52,53.    
 The UP element is an AT rich region upstream of the -35 element, typically located 
between positions -40 and -60. The UP element is recognized by the C-terminal domains of the 
RNAP  subunits rather than through , which mediates most of the holoenzyme’s interactions 
with promoter sequence elements 54. In addition to 70 region 4 binding the -35 element, the 
RNAP  interactions with the UP element are the first interactions between the holoenzyme and 
DNA 55. 
 The CRE is a guanosine at the +2 position of the non-template strand that interacts with 
RNAP  residues that form a base specific binding pocket for guanosine 8. First mention of what 
was later determined to be the CRE was observed when the portion of RNAP  that forms the 
CRE binding pocket was found to cross-link to positions -6 - +2 of the promoter 56.  Later 
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structural studies revealed why the crosslinking occurred by resolving a promoter bound 
holoenzyme structure with the +2 guanosine sequestered in a base specific binding pocket 8. 
 These six promoter sequence elements as a collective create many opportunities for the 
holoenzyme to recognize and interact with any given promoter. This flexibility in what can 
constitute a functional promoter results in a rich diversity of promoter architectures found within 
the bacterial genome. 
Promoter Melting 
 The holoenzyme stably bound to the DNA promoter prior to promoter melting is called 
the RNAP closed promoter complex (RPc). The holoenzyme then unwinds up to 13-bp of DNA 
from -11 to +2 to form a complex called the RNAP open promoter complex (RPo). The transition 
from RPc to RPo is collectively called isomerization and has been an area of active investigation 
for nearly 60 years. Our current understanding of isomerization was born out of extensive 
biochemical and genetic dissection of E. coli 70 holoenzyme activity on a handful of model 
promoters, which established that isomerization is a multi-step process 45,57–62. Understanding of 
isomerization is now being refined through the combination of technological breakthroughs in 
structural biology that are allowing isomerization intermediates to be captured and studies that 
compare isomerization in E. coli with other bacterial species 63–70. 
Isomerization begins with a group of highly conserved aromatic residues in  region 2.3 
unstacking -11A through a base flipping mechanism 71,72. After unstacking -11A, residues in  
region 2.3 sequester -11A in a binding pocket 73. The conserved amino acids that constitute the -
11A binding pocket make adenosine specific interactions allowing the -11 position of the -10 
element to be read 73.  The  region 2.3 adenosine specific binding pocket and the importance of 
this base in nucleating promoter melting explains why the -11A is the most conserved position 
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not only among the six positions constituting the -10 element but across all the promoter 
sequence elements utilized by housekeeping  bound holoenzyme in both E. coli and M. 
tuberculosis. Early promoter melting extends from position -11 to -8 with the DNA located 
outside of the holoenzyme primary cleft and the DNA clamp in the closed conformation 70. 
Propagation of promoter melting from the -8 to -4 position is thought to coincide with the 
removal of 70 region 1.1, which acts as a DNA mimic, from the holoenzyme primary cleft 70. 
Ejection of 70 region 1.1 from the primary channel now allows positions -8 to +2 of the ssDNA 
template strand to enter and occupy the primary channel 68,70. During this second phase of 
promoter melting -7T is sequestered in a base specific manner by a second  region 2.3 
nucleotide binding pocket 73. The invasion of DNA positions -8 to +2 of the ssDNA template 
strand into the primary channel likely requires temporary RNAP clamp opening before it closes 
again and then remains closed to the completion of isomerization 68,70,74. The final step is the 
melting from positions -4 to +2, which is paired with increased interactions between the RNAP 
clamp and downstream dsDNA, finally resulting in RPo 
70,75,76. In addition to the -11A and -7T 
positions being sequestered in binding pockets formed by  region 3.2, +2 can also be 
sequestered in a binding pocket formed by residues in , which all together stabilize RPo 
8. 
Promoter Escape 
 Once stable RPo has formed, the holoenzyme begins the process of promoter escape. 
During promoter escape a nascent transcript is formed while the holoenzyme maintains the 
contacts that are formed in RPo. The growth of the nascent transcript requires downstream DNA 
to be pulled into the RNAP resulting in a process called ‘scrunching’ 77,78. As more downstream 
DNA is pulled into the holoenzyme primary channel while the nascent RNA grows, the contacts 
between the RNAP and the promoter are strained 79. The increasing strain is relieved through one 
9 
 
of two ways. Either the contacts between the RNAP and promoter are broken allowing the 
RNAP to escape and progress forward to elongation or the nascent RNA transcript is released, 
the RNAP repositions at the transcription start site and the process restarts 80,81. The RNA that is 
released prematurely is called an abortive transcript and at some promoters several abortive 
transcripts will be produced 82. When the RNA transcript elongates to 5-6 nucleotides in length, 
the growing transcript collides with  region 3.2, a key event during RNAP’s ‘decision’ to 
progress to elongation or produce an abortive transcript 28,34. Region 3.2 of  blocks the RNA 
exit channel that the 5’ end of the transcript approaches as it grows 67,83. Therefore, the transcript 
must displace  region 3.2 in order to continue growing towards the RNA exit channel. If the 
transcript displaces  region 3.2, a conformational change in  occurs that initiates the breaking 
of -RNAP interactions and allows  dissociation from core RNAP for elongation.  
Elongation and Termination 
 The focus of this thesis is transcription initiation and therefore I have decided omit an in 
depth overview of transcription elongation and termination. However, both transcriptional 
elongation and termination in bacteria include an ever-growing number of important features and 
our current understanding of both topics have been reviewed elsewhere 84–87. 
Mycobacteria Transcription 
Unique Features of the Mycobacteria RNAP and Mycobacteria Promoter 
 The description of bacterial transcription included above is mostly derived from studying 
E. coli. This description is useful as a starting point, but a more complete understanding of 
bacterial transcription requires interrogating these processes in more than one species. 
Characterization of transcription in mycobacteria and identifying similarities and differences 
when compared to E. coli is broadening our understanding of transcription. By identifying 
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similarities between E. coli and mycobacteria transcription we gain insight into what features are 
similar across bacteria. Conversely, identifying differences better defines the Actinobacteria 
paradigm of bacterial transcription to complement the better understood -proteobacteria 
paradigm and points to ‘customizable’ features of transcription that can evolve to meet the needs 
of different bacterial species. 
Unique features of mycobacteria transcription include lineage specific insertions in the 
RNAP ’ subunit and A, unique promoter architecture and an Actinobacteria specific 
combination of two essential proteins that interact with the RNAP (Figure 4 and 5). The 
mycobacteria core RNAP subunit composition is like most bacteria and includes the  and ’ 
subunits, two  subunits and the  subunit. However, the mycobacteria ’ subunit harbors a 
lineage specific 90 amino acid insertion conserved in the Actinobacteria phylum 6. Another 
insertion occurs in mycobacteria’s housekeeping A, where there is a 163 amino acid tail 
attached the N-terminus giving mycobacteria an unusually long A domain 1.1. The 90 amino 
acid ’ insertion forms two anti-parallel  helices that protrude from the downstream facing 
RNAP clamp domains 10.  The function of the ’ insertion is unknown; however, the insertion is 
positioned such that it blocks the primary channel of the RNAP, hinting that this structure may 
play a role in regulating DNA’s entrance into the primary cleft during isomerization 10. The A 
domain 1.1 is predicted to be unstructured and has evaded resolution in all the mycobacteria 
RNAP structures published 10,67,68,88. E. coli 70 includes an N-terminal domain 1.1 that is shorter 
than its counterpart in mycobacteria and is known to occlude DNA from entering the primary 
cleft during transcription initiation among other functions. It is not yet clear whether 
mycobacteria’s A domain 1.1 performs the same roles as E. coli’s 70 domain 1.1. 
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In addition to the σA N-terminal domain 1.1, another unique σ-related feature of 
mycobacteria transcription is the cohort of alternative σ factors that with σA collectively make up 
the mycobacteria sigma factor network. The number of σ factors encoded in different 
mycobacterial species varies across a spectrum with M. smegmatis encoding a total of 26 σ 
factors and other species such as M. tuberculosis encoding only half as many. The M. 
tuberculosis σ factor network and the role of each σ factor within this network is the best 
characterized among the mycobacteria species. The 13  factors encoded in M. tuberculosis 
include one type I  factor (A), one type II  factor (B), one type III  factor (F) and 10 type 
IV  factors (C, D, E, G, H, I, J, K, L, M) 18,89. Only the housekeeping A is essential 
in mycobacteria. The 12 non-essential  factors collectively mediate M. tuberculosis adaptation 
to various stresses that the bacterium encounters in the human host.  An important feature of M. 
tuberculosis’s  factors is the complexity of the regulatory network that often includes multiple 
 factors working together to mount an appropriate stress response. The stresses each non-
essential M. tuberculosis  factor is important for has been reviewed elsewhere and include 
stationary phase, starvation, pH stress, high temperature, hypoxia, oxidative stress, surface stress, 
DNA damage, iron stress, antibiotics and interactions with macrophages 18,89.  
 Multiple analyses of mycobacteria promoters have shown that mycobacteria promoters 
differ from E. coli promoters in several ways and indicate that the mycobacteria promoter 
architecture is less stringently defined compared to that of E. coli 10,90–92. The consensus -10 
element in both bacteria includes -11A and -7T; however, aside from these two positions the 
identity of the other 4 positions (-12, -10, -9 and -8) is not defined in mycobacteria. The number 
of M. tuberculosis promoters that include the consensus -35 element and the identity of the 
consensus M. tuberculosis -35 element has varied depending on the criteria used to define the -35 
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element 10,90–92. With that said, even when the most liberal criteria are applied to determining 
whether a M. tuberculosis promoter contains a -35 element, the frequency at which -35 elements 
are found in M. tuberculosis promoters is half the frequency of that in E. coli 10. The UP element 
defined by tracts of AT-rich sequences bound by the C-terminal domain of the RNAP  subunits 
is also found less frequently in mycobacteria promoters compared to E. coli promoters 10, which 
is not surprising given the large difference in GC content between the genomes. Mycobacteria 
promoters include the extended -10 element at a frequency comparable to E. coli 10,90.  
 The cohort of transcription factors encoded in E. coli and mycobacteria differ. Two well 
characterized transcription factors, DksA and Fis, are notably absent in mycobacteria. DksA is a 
secondary channel binding protein important for E. coli’s stringent response and Fis is a nucleoid 
associated protein (NAP) important for organizing the architecture of the bacterial chromosome. 
Conversely, mycobacteria encode factors that E. coli lacks. Two of these factors are CarD and 
RNA polymerase binding protein A (RbpA). 
CarD 
Mycobacteria CarD was discovered by Christina Stallings in a screen identifying factors 
important for M. tuberculosis’s DNA damage response and is conserved in several bacterial 
phyla including Actinobacteria 93. CarD is comprised of two structural domains including the N-
terminal RNAP interaction domain (RID) and the C-terminal DNA binding domain (DBD)94,95. 
CarD’s RID binds to the RNAP  lobe on the downstream facing side of the RNAP while 
CarD’s DBD binds DNA non-specifically and through the activity of W85 that acts as wedge at 
the upstream edge of the transcriptional bubble in RPo 
94,96,97. The activities of both CarD’s 
domains are required for mycobacteria growth and viability, tolerance to clinically relevant 
antibiotics, expression of rRNA and M. tuberculosis replication in murine lung and spleen tissue 
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94,95,98. During logarithmic growth CarD activates and represses two distinct gene subsets that 
each constitute roughly one third of M. tuberculosis’s genes 99. ChIP-seq analysis of CarD 
localization in M. smegmatis showed that CarD is present at all promoters 100. These data show 
that CarD plays an important role regulating most if not all of M. tuberculosis’s gene expression. 
The mechanism by which CarD activates transcription at one set of promoters while repressing 
transcription at a second set of promoters is an active area of investigation in Eric Galburt’s lab 
and ours. Briefly, data so far points to a model where CarD increases RPo stability which in turn 
decreases promoter escape. Promoters with intrinsically high RPo stability and low rates of 
promoter escape are repressed by CarD while promoters with intrinsically low RPo and high 
promoter escape rates are activated 64,65,69,99.  
RbpA 
 RbpA was discovered in a screen identifying genes upregulated in Streptomyces 
coelicolor during disulfide stress 101. Many different types of stress including oxidative stress, 
stationary phase, starvation, high temperature, antibiotics and interactions with macrophages 
increase rbpA levels in M. tuberculosis 102–105. RbpA is conserved only among Actinobacteria 
and is essential in mycobacteria. RbpA is comprised of four structural domains including the N-
terminal tail (NTT), core domain (CD), basic linker (BL) and sigma interaction domain (SID) 
(Figure 4). Structures of RbpA bound RPo show that RbpA extends the length of the RNAP and 
interacts with several structural regions of the RNAP (Figure 5). The NTT interacts with or is 
positioned near the  switch 3 region, ’ lid,  region 3.2 and the ’ zinc binding domain (ZBD) 
67. RbpA CD interacts with ’ ZBD and ’ zipper 67,106. RbpA BL interacts with the DNA non-
template strand phosphate backbone at positions -13 and -14 upstream of the -10 element and 
RbpA SID interacts with the non-conserved region of  as well as regions 1.2 and 2.3 22. RbpA 
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forms a stable binary complex with M. tuberculosis A and B and increases A and B binding 
to core RNAP 107,108. In vitro, RbpA increases transcription by A and B holoenzyme.  
 The combined effect of RbpA and CarD on transcription initiation has been interrogated 
in vitro 65,69. Together RbpA and CarD increase A-bound M. tuberculosis RPo at the M. 
tuberculosis ribosomal RNA AP3 (rrnAP3) promoter to a level comparable to E. coli RNAP-70 
holoenzyme and to a high level of RPo than either factor can achieve individually 
65. However, 
CarD increases M. tuberculosis RNAP-σA RPo stability more than RbpA. Detailed kinetic 
analysis of CarD’s effect on RPo stability at different concentrations revealed that CarD increases 
RPo through a two-tier mechanism 
64. At low concentrations, CarD binds M. tuberculosis RNAP-
σA RPo and prevents transcription bubble collapse and at higher concentrations in excess of M. 
tuberculosis RNAP-σA RPo, CarD will bind M. tuberculosis RNAP-σ
A RPc
 and promote DNA 
melting to increase RPo. The comparison of M. tuberculosis RNAP-σ
A and E. coli RNAP-70 
RPo stability on the M. tuberculosis rrnAP3 highlighted an important difference in transcription 
initiation between the two bacterial species, highlighting the intrinsically higher E. coli RNAP-
70 RPo stabilizing activity.  During promoter escape, both RbpA and CarD individually decrease 
the rate of M. tuberculosis RNAP-σA promoter escape 69. Similar to RPo stabilizing activity, 
CarD has a greater impact on slowing M. tuberculosis RNAP-σA promoter escape. In the 
presence of both factors, the rate of promoter escape is increased compared to in the presence of 
CarD alone, indicating that RbpA can increase the rate of promoter escape in the context of 
CarD. These in vitro analyses together indicate that the combined activity of RbpA and CarD is 






































































































































Figure 5. Structure of RbpA and CarD bound M. tuberculosis RNAP-A holoenzyme with 















































Chapter 2: Domains within RbpA Serve Specific Functional Roles That 
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The RNA polymerase (RNAP) binding protein A (RbpA) contributes to the formation of 
stable RNAP-promoter open complexes (RPo) and is essential for viability in mycobacteria. Four 
domains have been identified in the RbpA protein, i.e., an N-terminal tail (NTT) that interacts 
with RNAP β’ and σ subunits, a core domain (CD) that contacts the RNAP β’ subunit, a basic 
linker (BL) that binds DNA, and a σ-interaction domain (SID) that binds group I and group II 
factors. Limited in vivo studies have been performed in mycobacteria, however, and how 
individual structural domains of RbpA contribute to RbpA function and mycobacterial gene 
expression remains mostly unknown. We investigated the roles of the RbpA structural domains 
in mycobacteria using a panel of rbpA mutants that target individual RbpA domains. The 
function of each RbpA domain was required for Mycobacterium tuberculosis viability and 
optimal growth in Mycobacterium smegmatis. We determined that the RbpA SID is both 
necessary and sufficient for RbpA interaction with the RNAP, indicating that the primary 
functions of the NTT and CD are not solely association with the RNAP. We show that the RbpA 
BL and SID are required for RPo stabilization in vitro, while the NTT and CD antagonize this 
activity. Finally, RNA-sequencing analyses suggest that the NTT and CD broadly activate gene 
expression, whereas the BL and SID activate or repress gene expression in a gene dependent 
manner for a subset of mycobacterial genes. Our findings highlight specific outcomes for the 
activities of the individual functional domains in RbpA. 
Introduction 
RbpA was discovered in Streptomyces coelicolor as a protein that coimmunoprecipitates 
with the RNAP and is unique to the Actinobacteria phylum 101. RbpA consists of a central core 
domain (CD) flanked by an unstructured 26-amino-acid N-terminal tail (NTT) and a C-terminal -
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interaction domain (SID) linked to the CD by a 15-amino-acid basic linker (BL) (Chapter 1, 
Figure 4)22,101,109,110. The RbpA SID forms a stable binary complex with group I (σA in M. 
tuberculosis) and certain group II (σB in M. tuberculosis) factors 22,101,106,110. Bacterial two-hybrid 
experiments in S. coelicolor showed that mutating the R88 residue within the RbpA SID to an 
alanine significantly weakened the interaction between S. coelicolor RbpA and the housekeeping 
HrdB 110, highlighting the importance of this residue in the interaction. Based on structural 
studies, the BL makes electrostatic contacts with the DNA phosphate backbone of the 
nontemplate strand upstream of the -10 promoter element in the RPo conformation, the CD is 
positioned near the RNAP β’ zinc binding domain, and the NTT threads into the RNAP active 
site cleft between the β’ zinc binding domain and the σA4 domain 
22,67,106. In support of a 
functional role for the BL, fluorescence anisotropy experiments showed that addition of M. 
tuberculosis RbpA to Mycobacterium bovis RNAP-σA holoenzyme in the presence of M. 
tuberculosis CarD decreased the dissociation constant (Kd) of RNAP binding to a vapB10 
promoter template and an R79A mutation in the M. tuberculosis RbpA BL abolished the RbpA 
mediated increases in RNAP affinity for the vapB10 promoter 22. Most characterization of RbpA 
has been performed in vitro, and there have been only limited studies of how the domains of 
RbpA contribute to gene regulation in mycobacteria. In a recent study using Mycobacterium 
smegmatis, an R79A mutation in the RbpA BL and deletion of the NTT and CD resulted in 
slower growth of the bacteria 106. Herein, we expand on that work and compare the roles of each 
RbpA domain, both in vitro and in vivo, to show that only the SID is required for association 
with the RNAP and the activities of different domains affect the expression of distinct gene sets 




Media and bacterial strains. (i) Mycobacterium tuberculosis. The Erdman strain was grown at 
37°C in 7H9 (broth) or 7H10 (agar) medium supplemented with 60 μl/liter oleic acid, 5 g/liter 
bovine serum albumin (BSA), 2 g/liter dextrose, and 0.003 g/liter catalase (oleic acid-albumin-
dextrose-catalase [OADC]), 0.5% glycerol, and 0.05% Tween 80 (broth). The M. tuberculosis 
merodiploid strain was constructed by integrating pMSG430-rbpAMtb
WT (expressing RbpAMtb
WT 
from a constitutive Pmyc1-tetO promoter; kanamycin resistant) into the attB site of the Erdman 
strain. A specialized transducing phage with homology to M. tuberculosis H37Rv nucleotides 
2307223 to 2307826 and 2303122 to 2308681 was used to replace all except the start and stop 
codons of the endogenous rbpA gene with a hygromycin resistance cassette in the merodiploid 
strain, thus generating ΔrbpA attB::tet-rbpAMtb
WT. Gene swapping was used to construct strains 
of mycobacteria expressing different rbpA alleles and to test their viability, as described 
previously 95,111. The M. tuberculosis ΔrbpA attB::tet-rbpAMtb
WT strain was transformed with 
pDB19-rbpAMtb
WT (expressing RbpAMtb
WT from a constitutive Pmyc1-tetO promoter; zeocin 
resistant) to replace the pMSG430-rbpAMtb
WT construct at the attB site of the M. tuberculosis 
ΔrbpA attB::tet-rbpAMtb
WT strain. The transformants were selected with zeocin, and loss of the 
pMSG430-rbpAMtb
WT construct was confirmed by verifying their inability to grow in the 
presence of kanamycin. The M. tuberculosis ΔrbpA::tet-rbpAMtb
WT strain transformed with 
pDB19-rbpAMtb










72–111, respectively, from a constitutive 
Pmyc-tetO promoter; kanamycin resistant) to replace the pDB19-rbpAMtb
WT construct at the attB 
site of csm323. The transformants were selected with kanamycin; when positive transformants in 







72–111 transformations), the 
mutations were deemed nonviable. (ii) Mycobacterium smegmatis. All M. smegmatis strains 
were derived from mc2 155 and grown at 37°C in LB medium supplemented with 0.5% dextrose, 
0.5% glycerol, and 0.05% Tween 80 (broth). The M. smegmatis merodiploid strain was 
constructed by integrating pMSG430-rbpAMtb
WT into the attB site of mc2 155. The M. smegmatis 
merodiploid strain was transformed with pDB88, with homology to mc2155 nucleotides 3928650 
to 3929246 and 3929589 to 3930405, to replace the endogenous rbpA, using two-step allelic 
exchange as described previously 112, thus generating ΔrbpA::tet-rbpAMtb
WT, which was named 
csm275. Csm275 was transformed with pDB19-rbpAMtb
WT to replace the pMSG430-rbpAMtb
WT 
construct at the attB site of the M. smegmatis ΔrbpA attB::tet-rbpAMtb
WT strain. The 
transformants were selected with zeocin, and loss of the pMSG430-rbpAMtb
WT construct was 
confirmed by verifying their inability to grow in the presence of kanamycin. The M. smegmatis 
ΔrbpA::tet-rbpAMtb
WT strain transformed with pDB19-rbpAMtb
WT was named csm291. Csm291 













72–111-FLAG to replace the pDB19-rbpAMtb
WT construct at the attB site of csm291. Each 
FLAG tag repeated the sequence for FLAG twice (2X FLAG). The transformants were selected 
with kanamycin, and loss of the pDB19-rbpAMtb
WT construct was confirmed by verifying their 
inability to grow in the presence of zeocin. When positive transformants in csm291 could not be 
obtained (as was the case for pMSG430-rbpAMtb
1–71 and pMSG430-rbpAMtb
1–71-FLAG 












111-FLAG were named csm322, csm314, csm328, csm313, csm329, csm327, and csm347, 
respectively.  
Antibiotics and chemicals. In mycobacterial cultures, 20 µg/ml kanamycin and 12.5 µg/ml 
zeocin were used. In E. coli cultures, 40 µg/ml kanamycin, 50 µg/ml chloramphenicol, 50 µg/ml 
streptomycin, and 100 µg/ml ampicillin were used.  
Western blotting and immunoprecipitation. For immunoprecipitation, 1-liter cultures were 
pelleted by centrifugation, resuspended in 20 ml of 1 phosphate-buffered saline (PBS) with 
complete protease inhibitor cocktail (Roche), and lysed with high-pressure (30 lb/in2) cell 
disruption (CF model; Constant Systems, Daventry, UK). The lysate was treated with DNase I 
(New England BioLabs), added to anti-FLAG affinity gel (clone M2; Sigma-Aldrich, St. Louis, 
MO), and rotated overnight at 4°C. The protein-agarose matrix was washed three times with NP-
40 buffer (10 mM sodium phosphate [pH 8.0], 150 mM NaCl, 1% Nonidet-40, 1 complete 
protease inhibitor cocktail). The immunoprecipitated protein complexes were eluted with 50 mM 
Tris-HCl (pH 7.5), 50 mM NaCl, 150 µg/ml FLAG peptide (SigmaAldrich), 1x complete 
protease inhibitor cocktail. Protein samples were mixed with SDS-PAGE loading buffer and run 
on a 4 to 12% Bis-Tris protein gel (Invitrogen). For the Western blot analysis, σA and σB were 
detected using a mouse monoclonal antibody against E. coli σ70 (clone 2G10; Neoclone, 
Madison, WI), RNAP β was detected using a mouse monoclonal antibody against E. coli RNAP 
β (clone 8RB13; Neoclone), and FLAG-tagged RbpA was detected using an anti-FLAG mouse 
monoclonal antibody (Sigma-Aldrich). Secondary LiCor IR Dye 800CW goat anti-mouse IgG 
polyclonal antibodies were used to detect the primary antibodies. Secondary antibody near-
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infrared fluorescence was detected with the LiCore Odyssey version 3.0 imaging system, and 
band intensity was analyzed with Image Studio Lite version 4.0.  
Protein purification for biochemical assays. Plasmids containing the Mycobacterium 
tuberculosis H37Rv genomic DNA encoding the different M. tuberculosis RNAP holoenzyme 
subunits were a gift from Jayanta Mukhopadhyay (Bose Institute, Kolkata, India) 113,114. 
Expression was carried out in accordance with the method described by Banerjee et al. 114, with 
minor exceptions. Briefly, E. coli BL21(DE3) cells were transformed with plasmids pET-Duet-
rpoB-rpoC (encoding the β and β’ subunits), pAcYc-Duet-sigA-rpoA (encoding an N-terminal 
10x His-tagged σA subunit and α subunit), and pCDF-rpoZ (encoding the ω subunit) and were 
grown in LB medium at 37°C to an optical density at 600 nm (OD600) of 0.6 to 0.8. The culture 
was then treated with 0.25 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and grown 
overnight at 16°C. Cells were harvested via centrifugation (4,070 x g for 15 min at 4°C), and the 
resultant pellets were stored at 80°C. M. tuberculosis RNAP-σA holoenzyme was purified 
according to methods used previously for the M. bovis RNAP core complex 115. M. tuberculosis 
RbpA constructs were cloned into pET-SUMO (Thermo Fisher Scientific) and transformed into 
E. coli BL21(DE3). Cultures were grown at 37°C to an OD600 of 0.8, and protein overexpression 
was induced with the addition of 0.5 mM IPTG overnight at 16°C. Cells were harvested by 
centrifugation (4,070 x g for 15 min at 4°C), and the cell pellets were stored at 80°C. The cells 
were resuspended in lysis buffer (50 mM NaH2PO4 [pH 8.0], 5 mM imidazole, 300 mM NaCl, 5 
mM β-mercaptoethanol, protease inhibitor [Sigma-Aldrich]) and lysed by sonication at 4°C. 
Soluble lysate was separated from insoluble lysate by centrifugation (2,700 x g for 20 min at 
4°C). RbpA was purified from the soluble lysate by Ni2+ affinity chromatography (Gold 
Biotechnology). Ni2+ columns were washed with wash buffer (50 mM Na2HPO4 [pH 8.0], 20 
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mM imidazole, 300 mM NaCl) until no protein was detected with NanoDrop spectrophotometer 
OD280 readings. RbpA was eluted from the Ni
2+ affinity columns with elution buffer (50 mM 
Na2HPO4 [pH 8.0], 250 mM imidazole, 300 mM NaCl, 5 mM β-mercaptoethanol). The His-
SUMO tag was cleaved from the RbpA constructs with His-Ulp1 protease during overnight 
dialysis at 4°C (20 mM Tris-HCl [pH 8.0], 250 mM NaCl, 20 mM imidazole, 1 mM β-
mercaptoethanol). The His-SUMO tag and His-Ulp1 were separated from RbpA by a second 
round of Ni2+ affinity chromatography, and the cleaved RbpA was collected as the flowthrough 
fraction. Cleaved RbpA was dialyzed overnight at 4°C in storage buffer (20 mM Tris-HCl [pH 
8.0], 250 mM NaCl, 1 mM β-mercaptoethanol), concentrated to approximately 200 µM 
(Vivaspin 20, molecular weight cutoff of 3,000; GE Healthcare), and stored at 80°C.  
Preparation of fluorescent promoter DNA template. A Cy3-labeled promoter template of 150 
bp 2+ nontemplate dT, containing nucleotides 1470151 to 1470300 of the M. tuberculosis 
Erdman genomic DNA, including the rrnAP3 promoter, was prepared as described previously 
65,115.  
Stopped-flow fluorescence assay. Stopped-flow experiments were performed as described 
previously 65,98,115, with notable exceptions. Prior to data acquisition, M. tuberculosis RNAP-σA 
holoenzyme, with or without RbpA protein, was incubated at 37°C for 10 min. All experiments 
were conducted with equal-volume mixing of 2 nM Cy3-labeled rrnAP3 promoter DNA with 70 
or 200 nM M. tuberculosis RNAP-σA holoenzyme, with or without 4 µM RbpA protein. Thus, 
the final concentrations upon mixing were 1 nM DNA and 35 or 100 nM RNAP-σA holoenzyme, 
with or without 2 µM RbpA protein. Accounting for all contributions from protein storage 
buffers, the final reaction buffer conditions upon equal-volume mixing were as follows: 20 mM 
Tris (pH 8.0), 77.5 mM NaCl, 10 mM MgCl2, 5 µM ZnCl2, 20 M EDTA, 5% (vol/vol) glycerol, 
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1 mM dithiothreitol, and 0.1 mg/ml BSA. Experiments were performed with an SX-20 stopped-
flow spectrophotometer (Applied Photophysics, Leatherhead, UK) with a dead time of 1 ms and 
a total shot volume of 100 µl. Samples were excited using a 535-nm fixed-wavelength light 
emitting diode (LED) light source with a 550-nm short pass filter, and emission was monitored 
using a 570-nm long pass filter. Data were collected at 37°C for 1,000 s by sampling 5,000 
points over a logarithmic decay. Each protein condition is represented by the average of at least 5 
shots obtained using multiple RNAP preparations, plotted as the fold change over DNA alone 
according to the formula (F - F0)/F0, where F0 is the buffer-subtracted reading for DNA alone 
and F is the buffer-subtracted reading for DNA mixed with protein.  
RNA-seq analysis. M. smegmatis strains csm275, csm322, csm314, and csm328 were cultured 
to an OD600 of 0.4 to 0.6, pelleted, resuspended in TRIzol (Thermo Fisher Scientific), and lysed 
by bead beating (FastPrep; MP Bio, Santa Ana, CA). RNA was extracted with chloroform, 
precipitated with isopropanol, and resuspended in water. RNA was treated with DNase I 
(Thermo Fisher Scientific), and RNA integrity and quality were analyzed with an Agilent 
bioanalyzer. rRNA was removed from samples using the Illumina Ribo-Zero rRNA removal kit. 
cDNA libraries were generated using an adapted Illumina TruSeq library preparation kit and 
were quality controlled by analysis of the cDNA size distribution with the Agilent TapeStation. 
cDNA libraries were pooled and sequenced in a single lane of an Illumina HiSeq 2000 Rapid 
Run flow cell with a 50-bp single-end read format. Sequencing reads were demultiplexed and 
converted to a FASTQ format using Illumina bcl2fastq script. Adapter sequences were trimmed 
from the raw reads, which were then aligned with the M. smegmatis mc2 155 reference genome 
(GenBank accession number NC_008596) using the STAR aligner 116. Sequence alignment map 
(SAM) files generated from alignments were converted to BAM files using SAMTools 117, and 
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aligned reads were counted per genome feature using the BioConductor package Subread 
featureCounts function 118. Differential expression analysis and subsequent PCA were performed 
with BioConductor DESeq2 119. Venn diagrams were made with an online tool 
(https://www.stefanjol.nl/venny). Hypergeometric P values and enrichment values were 
calculated using an online calculator (http://systems.crump.ucla.edu/hypergeometric). The 
hypergeometric distribution describes the probability of k successes in s draws, without 
replacement, from a population of size N that contains exactly M successes. N was defined at the 
total number of differentially expressed genes in the two RbpA mutant constructs being 
compared, s was defined as the number of differentially upregulated or downregulated genes in 
one RbpA mutant included in the comparison, M was defined as the number of differentially 
upregulated or downregulated genes in the second RbpA mutant included in the comparison, and 
k was defined as the number of differentially upregulated or downregulated genes shared by the 
two RbpA mutants in the comparison.  
qRT-PCR analysis. M. smegmatis strains csm275, csm322, csm314, and csm328 were cultured 
to an OD600 of 0.5 to 0.7, pelleted, resuspended in TRIzol (Thermo Fisher Scientific), and lysed 
by bead beating (FastPrep; MP Bio). RNA was extracted with chloroform, precipitated with 
isopropanol, and resuspended in water. MS2 bacteriophage RNA (Roche) was added to the 
bacterial RNA at a ratio of 1 ng of MS2 RNA per 1 billion bacteria, RNA was treated with 
DNase I (Thermo Fisher Scientific), and cDNA was synthesized with the Superscript III first-
strand synthesis system (Invitrogen). qRT-PCR was performed with a SYBR green qPCR kit 
(Bio-Rad), and MSMEG_0281, MSMEG_5302, MSMEG_1215, MSMEG_3966, 
MSMEG_3297, MSMEG_3499, MSMEG_3855, MSMEG_1680, MSMEG_2259, 
MSMEG_4222, MSMEG_2758, MSMEG_2528, MSMEG_4497, MSMEG_6466, 
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MSMEG_6947, and MSMEG_2387 transcript levels were measured and normalized to spike-in 
MS2 RNA transcript levels. Primers are listed in Table S3 in the supplemental material.  
Accession number(s). The data discussed in this publication have been deposited in the NCBI 
Gene Expression Omnibus 120 and are accessible through GEO Series accession number 
GSE107123. 
Results 
Individual RbpA structural domains are important for mycobacterial growth and viability. 
To distinguish the roles of the RbpA structural domains in mycobacteria, we first 
engineered merodiploid strains of M. tuberculosis and M. smegmatis that expressed rbpAMtb at 
the chromosomal attB site. The M. smegmatis and M. tuberculosis RbpA proteins are 92% 
identical. Expression of rbpAMtb at the attB site allowed deletion of the endogenous rbpA gene in 
both M. tuberculosis and M. smegmatis, demonstrating that the RbpA protein from M. 
tuberculosis can substitute for the M. smegmatis RbpA protein to support viability. We then 





72–111, using a previously 
described gene-swapping method 95,111. The R79A mutation is within the BL and should disrupt 
DNA binding, the R88A mutation in the SID has been shown to weaken the affinity of RbpA for 
σ, the position 1 to 71 RbpA fragment is deleted for the BL and SID, and the position 72 to 111 
RbpA fragment is deleted for the NTT and CD 22,109,110. Using the gene-swapping approach, we 
found that none of the RbpA mutants could support viability in M. tuberculosis, demonstrating 
that M. tuberculosis is highly sensitive to any kind of disruption in RbpA function (Figure 1a). 
In contrast, all of the mutant rbpA alleles except that encoding RbpAMtb
1–71 supported viability 
of M. smegmatis, thus providing us with a genetic system to study M. tuberculosis RbpA in 
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72–111. The inability to obtain strains expressing the RbpAMtb
1–71 allele as the 
only rbpA allele demonstrated that the RbpA BL and SID are required for viability in 
mycobacteria. 
To determine how each of these mutations in RbpA affected mycobacterial growth, the 
doubling times of M. smegmatis strains expressing the wild type (WT), RbpAMtb




72–111 were measured. The doubling times of the 
RbpAMtb
R79A (4.3 h) and RbpAMtb
R88A (4.4 h) strains were significantly longer than that of the 
RbpAMtb
WT strain (3.2 h), indicating that the functions performed by the RbpA BL and SID are 
required for optimal M. smegmatis growth (Figure 1a and 1b). Although the growth rate of the 
RbpAMtb
72–111 (3.9 h) strain trended lower than that of the RbpAMtbWT strain, this difference was 
not statistically significant, indicating that loss of the RbpA NTT and CD has only a mild effect 
on M. smegmatis growth. 
To determine whether the mutations in RbpA affected the RbpA protein levels in M. 











72–111-FLAG proteins in cell lysates by 
Western blot analysis. The levels of RbpAMtb
R88A-FLAG protein were significantly lower than 
the levels of RbpAMtb
WT-FLAG (data not shown). Therefore, the slower growth of the M. 
smegmatis strain expressing RbpAMtb
R88A could in part be a result of lower levels of RbpA 
protein. The levels of RbpAMtb
72–111-FLAG protein were also significantly lower in cell lysates, 
compared to the levels of RbpAMtb
WT-FLAG. However, we found that this decrease in band 
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intensity was due to issues with the detection of RbpAMtb
72–111-FLAG with the anti-FLAG 
antibody. Therefore, it is unclear whether deletion of the RbpA NTT and CD decreases the levels 
of RbpAMtb
72–111-FLAG in cell lysates. 
The RbpA SID is necessary and sufficient for association with RNAP. 
Structural studies indicate that RbpA engages in four different macromolecular 
interactions in mycobacterial RNAP-promoter initiation complexes, i.e., (i) the RbpA NTT 
binding to RNAP β′ and σ, (ii) the RbpA CD binding to RNAP β′, (iii) the RbpA BL binding to 
DNA, and (iv) the RbpA SID binding to σ 22,106,109; however, it is not known which of these 
interactions are required for the association of RbpA with the RNAP. To address this gap in 
knowledge, we performed coimmunoprecipitation experiments analyzing the amounts of σA, σB, 
and RNAP β subunit that coimmunoprecipitated with the RbpA-FLAG-tagged proteins. The 
levels of σA and σB coimmunoprecipitated with RbpAMtb
R88A-FLAG were dramatically reduced, 
compared to those coimmunoprecipitated with RbpAMtb
WT-FLAG, as expected based on the 
importance of R88 for σ binding 110 (Figure 2a – 2c). In addition to the decreases in σA and 
σB levels, the levels of RNAP β coimmunoprecipitated with RbpAMtb
R88A-FLAG were 
significantly reduced (Figure 2a and 2d). In crystallographic studies, the R88 in the RbpA SID 
is not positioned to bind directly to the core RNAP subunits; therefore, we conclude that the 
reduced β coimmunoprecipitated with RbpAMtb
R88A-FLAG is due to the reduced RbpA-σ 
interaction. This indicates that the interaction between the RbpA SID and the σ subunit is the 
primary determinant of the association of RbpA with the RNAP. In contrast, deletion of the NTT 
and CD (RbpAMtb
72–111) did not decrease the amounts of RNAP β, σA, or σB associated with 
RbpA (Figure 2a – 2d). Therefore, despite the observations that the CD was positioned to 
interact with RNAP β′ and the NTT was positioned to interact with RNAP β′ and σ 67,106, these 
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interactions are not necessary for association with RNAP. Notably, although the levels of RNAP 
β, σA, and σB coimmunoprecipitated per molecule of RbpAMtb
72–111 appear to be increased in, we 
found that the differences were due to lower levels of RbpAMtb
72–111 detection by Western blot 
analysis (data not shown). RbpAMtb
R79A-FLAG coimmunoprecipitated similar levels of β and σA, 
compared to RbpAMtb
WT-FLAG (Figure 2a, 2b and 2d). Coimmunoprecipitated levels of 
σB trended higher with RbpAMtb
R79A-FLAG but were not statistically significantly different from 
those observed with RbpAMtb
WT-FLAG (Figure 2a and 2c). Collectively, our data show that the 
RbpA SID is both necessary and sufficient for interaction with RNAP. 
RbpA mutants exhibit distinct kinetic phenotypes on the pathway to RPo formation.  
RbpA has been proposed to accelerate a forward kinetic step in the formation of RPo, 
resulting in more stable RPo at equilibrium 
65,106. A real-time fluorescence assay 65 was used to 
determine the effects of RbpA mutants on RPo formation by the M. tuberculosis RNAP. Briefly, 
a Cy3 label was incorporated onto the +2 dT nucleotide, with respect to the +1 transcription start 
site, of the nontemplate strand of the M. tuberculosis rRNA rrnAP3 promoter 121. The Cy3 label 
is positioned within the transcription bubble such that, upon opening of the promoter DNA, a 2-
fold fluorescence enhancement is observed 81; this allows quantitation of the kinetics of 
RPo equilibration, by monitoring the change in fluorescence as a function of time, and the 
stability of RPo, by using the equilibrium fluorescence value 
65,98,115. Incubating RbpAMtb
WT at a 
saturating concentration (2 μM) with 35 nM M. tuberculosis RNAP-σA holoenzyme and the Cy3-
labeled rrnAP3 promoter resulted in a greater amount of RPo at equilibrium than observed with 
RNAP-σA holoenzyme and the rrnAP3 promoter alone, consistent with the known role of RbpA 
in stabilizing the otherwise unstable mycobacterial RNAP open complex 10,65. When the same 
concentrations of RbpAMtb
R79A and RbpAMtb
R88A were added, no enhancement of the amount of 
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RPo at equilibrium over RNAP-σ
A holoenzyme and the rrnAP3 promoter alone was observed 
(Figure 3a and 3b), demonstrating the importance of these residues. For a qualitative 
description of the kinetics, we calculated t1/2 values (the time required to reach the midpoint of 
the final equilibrium fluorescence). Interestingly, these mutants exhibited approximately 3-fold 
faster kinetics (RbpAMtb
R79A t1/2 of 14.8 ± 1.1 s and RbpAMtb
R88A t1/2 of 16.4 ± 1.1 s), compared 
with the RNAP-σA holoenzyme and the rrnAP3 promoter alone (t1/2 of 43 ± 2 s) (Figure 3a and 
3c). The finding of faster kinetics accompanied by no change in the equilibrium fluorescence 
value suggests that these mutants retain the ability to stabilize the transition state on the pathway 
to RPo but have lost the ability to stabilize RPo itself. This behavior is analogous to the classic 
model for enzyme activity 122, in which the transformation of substrate to product is accelerated 
without changes in the final equilibrium between the two states. In this scenario, the mutant 
RbpA proteins may increase the rate of opening and the rate of closing equally, such that the 
ratio of rates remains constant. These results suggest that the interactions between RbpA and 
both the promoter DNA (R79) and σ factor (R88) are essential for RPo stabilization and that 
RbpA is still capable of catalyzing promoter opening even in the presence of these mutations. 
 To further investigate the domain requirements for RPo stabilization, we repeated the 
experiments described above with RbpAMtb
1–71 (containing the NTT and CD) and RbpAMtb
26–
71 (containing the CD only), and we observed minimal enhancement in RPo stability and an 
identical rate of RPo equilibration (t1/2 of 42 ± 3 s), relative to the RNAP-σ
A holoenzyme and 
the rrnAP3 promoter alone, indicating that the NTT and CD are unable to affect RPo stability on 
their own (Figure 3a – 3c). Conversely, RbpAMtb
72–111 showed the greatest amount of RPo at 
equilibrium, even higher than that of RbpAMtb
WT, with kinetics (t1/2 of 7.8 ± 0.9 s) similar to 
those of RbpAMtbWT (t1/2 of 6.9 ± 0.5 s). The finding that RbpAMtb
72–111 exhibits similar 
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kinetics but a greater amount of RPo at equilibrium, compared with RbpAMtb
WT, raises the 
possibility that the NTT and CD negatively affect RbpA activity under these conditions. To 
determine whether it was the NTT and/or the CD that antagonized RbpA-mediated 
RPo stabilization, we assayed an RbpA protein with deletion of just the NTT (RbpAMtb
26–111). 
RbpAMtb
26–111 yielded a greater fold change in fluorescence than did RbpAMtbWT but smaller 
change than did RbpAMtb
72–111, suggesting that both the CD and NTT are responsible for the 
antagonistic effect on RbpA-dependent RPo stability. RbpAMtb
26–111 exhibited approximately 2-
fold slower kinetics of RPo equilibration (t1/2 of 17.6 ± 1.2 s) than did RbpAMtb
72–111 (t1/2 of 7.8 ± 
0.9 s) and RbpAMtb
WT (t1/2 of 6.9 ± 0.5 s). One possibility consistent with this observation is that, 
in the presence of the rest of the domains, the NTT decreases the amount of RPo at equilibrium 
by increasing a reverse rate leading toward the RNAP-promoter closed complex (RPc). 
Importantly, performing these experiments with multiple RNAP concentrations suggests that the 
effect of each RbpA construct is limited by DNA-bound kinetic intermediates and not the rates 
of association and dissociation of RNAP to and from promoter DNA. Taken together, these 
results suggest that residues R79 and R88 are essential for RPo stabilization and that the NTT and 
CD can inhibit RPo formation. 
Truncation of the RbpA NTT/CD and mutations in the RbpA BL and SID result in distinct 
gene expression changes in M. smegmatis. 
To determine how the individual RbpA domains contribute to gene expression, we 





WT. The only previous analysis of this type 
focused on the gene expression profiles that resulted from deletion of the RbpA NTT and CD 
in M. smegmatis, but it did not investigate the roles of the other RbpA domains 106. Principal-
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component analysis (PCA) of the RNA-seq data was performed and provided a general overview 
of how gene expression patterns among the RbpA mutants clustered in relationship to each other. 
Three distinct sample clusters were apparent from the PCA results (Figure 4a), indicating three 
different gene expression patterns. The first cluster included the three RbpAMtb
WT replicates, the 
second cluster included the three RbpAMtb
72–111 replicates, and the third cluster included the 
replicates from both RbpAMtb
R79A and RbpAMtb
R88A. The PCA results indicate that loss of the 
RbpA NTT/CD affects a gene subset that is different from the genes affected by mutations in the 
RbpA BL and SID. The number of genes significantly (adjusted p values of <0.05) upregulated 
or downregulated 2-fold in the RbpA mutants varied, with 766 genes being differentially 
expressed in RbpAMtb
72–111, compared to 199 genes in RbpAMtb
R79A and 244 genes in 
RbpAMtb
R88A (Figure 4b). 
 Consistent with the PCA results, there was significant overlap in upregulated and 
downregulated genes between the RbpAMtb
R79A and RbpAMtb
R88A strains (Figure 4c and 4d), 
indicating that the SID and BL perform functions that contribute to the expression of a common 
subset of M. smegmatis genes. Also consistent with the PCA results, the upregulated and 
downregulated genes in RbpAMtb72–111 had little overlap with those in either RbpAMtb
R79A or 
RbpAMtb
R88A (Figure 4c and 4d). Therefore, the number of shared downregulated or upregulated 
genes between RbpAMtb
72–111 and either RbpAMtb
R79A or RbpAMtb
R88A was under enriched (Figure 
4c and 4d). 
 Given that RbpA stabilizes RNAP-σA-rrnAP3 RPo in vitro and the R79 and R88 residues 
are essential for this activity, it might be expected that the RbpA BL and SID cooperate to 
activate transcription from all promoters that RbpA regulates. Similarly, the ability of the NTT 
and CD to antagonize RbpA-mediated RPo stabilization would lead to the hypothesis that 
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expression from RbpA-regulated genes would be increased in their absence. However, this was 
not supported by the RNA-seq data, in which similar numbers of transcripts were upregulated 
and downregulated in each RbpA mutant (Figure 4b). These data could mean that domains 
within RbpA can promote both activation and repression of gene expression. However, it is also 
possible that there was general downregulation or upregulation of gene expression in the RbpA 
mutants that we were unable to detect due to the addition of equal amounts of RNA from each 
strain into the sequencing reaction. To explore this possibility, we performed spike-in 
experiments 123 in which we isolated RNA from cultures of M. smegmatis expressing 
RbpAMtbR79A, RbpAMtbR88A, RbpAMtb72–111, or RbpAMtbWT and added 1 ng of MS2 
bacteriophage RNA (Roche) per 1 billion bacterial cells to the RNA samples. cDNA was 
generated for each sample, and quantitative reverse transcription-PCR (qRT-PCR) was 
performed to determine transcript levels for 16 M. smegmatis genes relative to MS2 RNA, which 
was used as a proxy to represent cell number. The 16 M. smegmatis genes analyzed included 
genes that were significantly upregulated or downregulated in RbpA mutants during RNA-seq 
experiments. When results were normalized to MS2 RNA levels, all 16 genes, including the 
genes considered highly upregulated in the RNA-seq analysis, were downregulated in 
RbpAMtb
72–111 compared to RbpAMtb
WT, suggesting that overall transcript levels in RbpAMtb
72–
111 are decreased (Figure 4e). Therefore, despite the findings that deletion of the NTT and CD 
had only a mild effect on the growth rate (Figure 1b and 1c) and enhanced RPo stabilization 
activity in vitro (Figure 3a and 3b), the NTT and CD are required for WT levels of gene 
expression in M. smegmatis. In contrast, qRT-PCR results for the RbpAMtb
R79A and 
RbpAMtb
R88A mutants were similar to the RNA-seq results, indicating that RbpAMtb
R79A and 
RbpAMtb
R88A mutants do indeed lead to both upregulation and downregulation of gene 
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expression. When we analyzed the genes that were most upregulated or downregulated with the 
RbpAMtb
R79A and RbpAMtb
R88A mutants, they fell into multiple diverse functional classes, 
indicating that RbpA activity likely affects multiple cellular processes. 
Discussion 
In this study, we investigated the functions of the individual RbpA structural domains to 
gain insight into the complex in vivo roles of RbpA. To study the roles of the RbpA NTT and 
CD, we truncated the N-terminal 71 amino acids of RbpA. The role of the RbpA BL was probed 
using a point mutation at R79, which has been implicated in the interaction between RbpA and 
DNA 22. Finally, we investigated the RbpA SID by using a point mutation at R88, which is one 
of the key residues needed for the interaction between RbpA and 110 but had yet to be studied in 
mycobacteria in vivo. We found that the function of each RbpA structural domain is required for 
M. tuberculosis viability and wild-type growth rates in M. smegmatis and disruption of the RbpA 
BL and SID functions causes a more severe growth defect than loss of the NTT and CD (Figure 
1) Our data indicate that M. tuberculosis has a more stringent requirement for RbpA activity, 
similar to what we observed for CarD 94,95.  
We determined that the RbpA SID interaction with is the only interaction required for the 
association of RbpA with the RNAP; the RbpA R88A substitution resulted in not only loss of the 
interactions with σA and σB but also almost complete loss of association with the core RNAP 
subunit (Figure 2). In contrast, deletion of the NTT and CD did not negatively affect the 
association of RbpA with RNAP, suggesting that the RbpA NTT and CD serve functions distinct 
from interaction with RNAP. The RbpA R88A substitution also resulted in decreased RbpA 
protein levels. Previous studies investigating CarD mutants with altered affinities for the RNAP 




R88A has a lower affinity for the RNAP and is present in lower abundance in the cell 
supports a model in which RbpA protein levels are also affected by its ability to interact with the 
RNAP. CarD was shown to be a target of the Clp protease in M. tuberculosis and, similarly, 
RbpA levels were >2-fold higher in a M. tuberculosis strain lacking Clp protease subunits, 
suggesting that RbpA protein levels may also be regulated by the Clp protease 124.  
Previous studies investigating the effect of RbpA on RPo stability reported that R79 is 
required for RPo stabilization, whereas both the NTT and CD are dispensable 
65,106. We have 
expanded on these findings by determining that the RbpA- interaction is required for enhanced 
RPo stability and the NTT and CD antagonize this activity (Figure 3). Furthermore, our results 
suggest that the effect of RbpA on the kinetics of RPo equilibration can be differentiated from its 
effect on equilibrium levels of RPo and that RbpA can affect both forward and reverse rates on 
the pathway to RPo, at the concentrations tested. The similar effects of RbpA BL and SID 
mutations on RPo stabilization (Figure 3) mirror the significant overlap in the expression profiles 
of RbpAMtb
R79A and RbpAMtb
R88A (Figure 4). In contrast, the truncation of NTT and CD, which 
affects RPo stability differently than mutations in RbpA BL and CD, results in an expression 
profile significantly different from that of RbpAMtb
R79A and RbpAMtb
R88A. We have found that 
RbpAMtb
R79A and RbpAMtb
R88A mutants can result in both upregulation and downregulation of 
transcript levels in M. smegmatis, depending on the gene. Upregulation of gene expression in 
RbpA mutants could be due to direct effects with RbpA acting as a repressor in some promoter 
contexts, due to differences in basal initiation kinetics. However, this observation could also be 
explained by indirect effects with RbpA enhancing the expression of a transcription factor that 
represses the expression of a set of genes. Future studies that expand analysis of RbpA past the 
limited promoters that have been explored in vitro will be necessary to address these 
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possibilities. Our data from spike-in control qRT-PCR experiments suggest that gene expression 
is globally downregulated in the M. smegmatis RbpAMtb
72–111 mutant. This suggests that the NTT 
and CD are required for efficient gene expression, and it complicates interpretations of the 
RbpAMtb
72–111 RNA-seq data in this study. This finding may also have an impact on a previously 
published RNA-seq data set for the M. smegmatis RbpAMtb
72–111 strain 106. When we compared 
our RNA-seq data set for RbpAMtb
72–111 with the previously reported data, we found that there 
was no significant overlap in genes that registered as upregulated or downregulated. This could 
be due to a difference in the culturing methods used in the two studies and/or it could be related 
to the finding that gene expression in general is less robust. How the NTT and CD 
mechanistically promote efficient gene expression while antagonizing RPo stability on the 
rrnAP3 promoter in vitro remains an open question for future studies. 
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Figure 1. Individual RbpA structural domains are important for mycobacterial growth and 
viability 
a. Viability of mutant RbpA constructs, RbpAMtbR79A, RbpAMtbR88A and RbpAMtb72-111 in 
M. tuberculosis and M. smegmatis. 




c. Doubling times of M. smegmatis strains expressing RbpAMtbWT, RbpAMtbR79A, 
RbpAMtb
R88A or RbpAMtb
72-111 calculated from growth curves as shown in (b). Results 
are plotted as ± standard deviation. Statistical significance was analyzed by analysis 
of variance (ANOVA) and Tukey’s multiple comparison test. *, p < 0.05; **, p < 













Figure 2. The RbpA SID is necessary and sufficient for association with RNAP 
 
a. Western blot analysis of lysates immunoprecipitated for FLAG-tagged RbpA. 
Monocolonal antibodies specific for FLAG were used to detect RbpAMtb – FLAG 
protein variants (bottom row). RNAP β, and both σA and σB were detected using a 
monoclonal antibody specific for a shared epitope in E. coli σ70. 
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b – d. Amounts of σA (b), σB (c) and RNAP β (d) coimmunoprecipitated by RbpA, based 
on band intensity, and expressed as the ratio of σA, σB or RNAP β to RbpA, with eight 
replicates for each strain. Results are shown as means ± standard deviations. Statistical 
significance was determined by one-way ANOVA and Kruskal-Wallis multiple-





















Figure 3. RbpA mutants exhibit distinct effects on RPo formation.  
a.  Fluorescence fold changes, compared to DNA alone, which were was used to monitor 
RPo formation and stability in real time, using fixed amounts of M. tuberculosis RNAP -
σA (35 nM), Cy3-labeled ( + 2 thymine nontemplate strand) M. tuberculosis rrnAP3 
promoter DNA (1 nM), and RbpA (2 µM). Time courses are shown as an average of at 
least 5 replicates.  
47 
 
b. Total fluorescent fold changes, normalized to RNAP- σA on rrnAP3 alone, for all RbpA 
constructs.  
c. t1/2 values, calculated as the time required to reach one-half of the final fluorescence 
intensity, for each sample. For panels (b) and (c), means standard errors of the means are 
plotted. Statistical significance was analyzed by ANOVA and Tukey’s multiple-
comparison test. *, p < 0.05; **, p < 0.01; ****, p < 0.0001; ns, not significant. Only 









Figure 4. Truncations of RbpA NTT/CD and mutations in the RbpA BL and SID result in 
distinct gene expression changes in M. smegmatis 
a. PCA results showing samples distances across two principal components, generated 





72-111, mapped to the M. smegmatis mc2155 
genome and normalized with regularized logarithmic transformation. Each represents 





b. Number of genes significantly (adjusted p values of < 0.05) upregulated or 




72-111, relative to M. smegmatis expressing RbpAMtb
WT. FC, fold change. 
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c. Venn diagram showing overlap of the genes downregulated 2-fold (adjusted p value 




72-111, relative to M. smegmatis expressing RbpAMtb
WT. 
d. Venn diagram showing overlap of the genes upregulated 2-fold (adjusted p value of < 




111, relative to M. smegmatis expressing RbpAMtb
WT. 




72-111, relative to M. smegmatis expressing 
RbpAMtb
WT. Transcript levels were normalized to a MS2 RNA spike-in control that 
was added at a constant level of 1ng/billion cells. Means ± standard errors of the 


































Chapter 3: Molecular Dissection of RbpA-Mediated Regulation of 

























RNA polymerase (RNAP) binding protein A (RbpA) is essential for mycobacterial 
viability and regulates transcription initiation by increasing RNAP-promoter open complex (RPo) 
stability. RbpA consists of four structural domains: a N-terminal tail (NTT), core domain (CD), 
basic linker (BL), and sigma interaction domain (SID). The roles of the BL and SID have been 
studied extensively, whereas, understanding of the NTT and CD is still limited. Truncation of the 
RbpA NTT and CD increases RPo stabilization by RbpA in vitro, implying that these domains 
antagonize this activity of RbpA. Structural studies show that the NTT and CD are positioned 
near multiple RNAP-σA holoenzyme functional domains, suggesting that the RbpA NTT and CD 
could have a number of effects on RNAP activity and it is unclear what contacts mediate the 
antagonism of RPo stability. In addition, structural studies predict that the RbpA NTT contributes 
contacts to the binding site for the antibiotic fidaxomicin (Fdx) on RNAP. Deletion of the NTT 
results in a decrease in Mycobacterium smegmatis sensitivity to Fdx, but whether this is caused 
by a loss of contacts with Fdx has yet to be tested. To address these gaps in knowledge, we 
generated a panel of rbpA mutants with single amino acid substitutions in conserved residues 
within the NTT to probe what residues are involved in regulating Fdx activity and RPo stability. 
We find that the NTT along with other RbpA domains and CarD contribute to Fdx activity in 
vivo, while in vitro the RbpA NTT residues that directly interact with Fdx are only partially 
responsible for RbpA NTT dependent Fdx activity. We identify roles for conserved RbpA NTT 
residues in RbpA NTT antagonism of RPo stabilization and determine that the loss of RbpA NTT 
decreases full-length transcription. This finding provides the first in vitro evidence that RbpA 
RPo stability can directly inhibit full-length transcription supporting the model that RbpA 




Compared to RbpA BL and SID much less is known about the functions performed by 
the RbpA NTT and CD. Deletion of the RbpA NTT increases RbpA RPo stabilizing activity and 
deletion of both the RbpA NTT and CD further increases RbpA RPo stabilizing activity, 
indicating that both domains antagonize RbpA RPo stabilizing activity 
125.  Structural analysis of 
RbpA bound to the M. tuberculosis RNAP-σA RPo shows that the RbpA NTT is positioned near 
the RNA exit channel, possibly contacting the RNAP β switch 3 region (Sw3), β flap, β’ lid, σA 
region 3.2 (σA3.2, also referred to as the σ “finger” domain), and the  β’ zinc binding domain 
(ZBD), while the RbpA CD is positioned near the RNAP β’ zipper and RNAP β’ ZBD 67,106. 
These RNAP structural domains have been characterized to varying levels in E. coli, which lacks 
RbpA. The RNAP β Sw3 is one of five switch regions that are thought to undergo 
conformational changes during transcription initiation 126. RNAP β Sw3 is positioned near the 
template DNA -3 and -4 nucleotides, raising the possibility that RNAP β Sw3 could play a role 
in DNA template strand positioning 6. The RNAP β flap, which includes the flap tip helix that 
interacts with σ region 4, is important for positioning σ region 4 for interaction with the -35 
element of the promoter 127 and represents a common binding interface for transcription factors 
that directly interact with σ 128,129. The RNAP β’ lid separates the RNA/DNA hybrid as part of 
the RNA exit channel and is required for RPo stability and transcription in E. coli and Thermus 
aquaticus 130,131. RNAP σ703.2 plays a role in initiating nucleotide triphosphate (iNTP) binding by 
positioning the DNA template strand for interaction with -4 and -5 nucleotides of the DNA 
template strand, which affects abortive transcription and promoter escape 28–31. Both the RNAP 
β’ ZBD and β’ zipper facilitate RPo formation on promoters with -35 elements that form weak 
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interactions with σ by making promoter contacts within the spacer region between the -10 and -
35 motifs 132,133.  
The positioning of the RbpA NTT and CD near multiple different structural and 
functional domains of the RNAP-σA holoenzyme implies that the RbpA NTT and CD could 
impact RNAP activity through a number of mechanisms. However, it is unclear what contacts 
between the RbpA NTT/CD and the RNAP mediate the antagonism of RPo stability. In addition, 
structural studies indicate that the RbpA NTT is positioned in the RNAP-σA holoenzyme 
complex in such a way that it contributes to the binding site for the antibiotic fidaxomicin (Fdx) 
67.  Fdx inhibits transcription initiation by binding the RNAP and blocking the closing of the 
RNAP clamp that occurs during RPo formation 
67,88. Deletion of the RbpA NTT decreases 
sensitivity to Fdx in vitro and in vivo 67, which is proposed to be due to the loss of RbpA’s 
contribution to the RNAP-Fdx binding interface. However, given that RbpA NTT also decreases 
RPo stability 
106,125 and is predicted to interact with the σA3.2, which is known to affect Fdx 
activity 67,134, it is possible that RbpA may impact Fdx activity by additional mechanisms. In this 
study, we interrogate the roles played by conserved residues within the NTT in RbpA-dependent 
Fdx sensitivity and RPo stabilization. In addition, we link NTT antagonism of RPo stability to 
increased full length transcript production, suggesting that decreasing RPo stability could allow 
for the transition of the RNAP-RbpA complex through transcription initiation and promoter 
escape. 
Experimental Procedures 
Media and bacterial strains. All Mycobacterium smegmatis strains were derived from mc2155 
and grown at 37oC in LB medium supplemented with 0.5% dextrose, 0.5% glycerol and 0.05% 




















72-114 were engineered 
using pMSG430 plasmids that express each rbpA allele from a constitutive Pmyc1-tetO promoter 
and integrate into the the attB site of the M. smegmatis rbpA attB::tet-rbpA strain previously 















R88A were named 
csm455, csm461, csm456, csm457, csm458, csm451, csm462, csm450 and csm498, csm510, 
csm511, csm322 and csm314 respectively. 
Protein Preparation for biochemical assays.  Plasmids containing the M. tuberculosis H37Rv 
genomic DNA encoding the different M. tuberculosis RNAP holoenzyme subunits were a gift 
from Jayanta Mukhopadhyay (Bose Institute, Kolkata, India) 113,114. Expression and purification 
were carried out in accordance with the methods described previously in 125. Recombinant M. 
tuberculosis RbpA proteins were purified from E. coli as previously described 125. RbpA was 
stored at -80oC 150 mM NaCl, 20 mM Tris pH 8.0, and 1 mM -mercaptoethanol. M. 
tuberculosis RNAP-A holoenzyme was stored at -80oC in 50% glycerol, 10 mM Tris pH 7.9, 
200 mM NaCl, 0.1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM MgCl2, and 20 μM 
ZnCl2. 
Fidaxomicin Zone of Inhibition. M. smegmatis cultures were grown to OD600 = 0.4 - 0.8. Based 
on the approximation that OD600 = 1.0 is equivalent to 5 x 10
8 mycobacteria, 2.5 x 108 cells were 
collected, resuspended in 100 μl of LB, and plated on LB agar plates. Whatman filter paper disks 
were applied to the plates and 10 μl of 100 μM, 250 μM, or 500 μM fidaxomicin (Selleck 
Chemicals) resuspended in DMSO or DMSO alone were added to the Whatman filter paper 
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disks. The plates were incubated at 37oC for 48 hours and the zones of inhibition were measured. 
The zone of inhibition for each replicate at each drug concentration is the average of four 
measurements approximately 90o apart. 
3-nucleotide in vitro transcription assay. Linear 150bp dsDNA template containing the M. 
tuberculosis rrnAP3 promoter with no internal modifications was prepared by annealing and 
extending 85-mer oligonucleotide primers (Integrated DNA Technologies, Coralville, IA) with a 
20-nt overlap ranging from nucleotides 1,471,577 - 1,471,726 in the M. tuberculosis H37Rv 
genome 69 and HPLC purified as previously described 64. RbpA (saturating concentration), M. 
tuberculosis RNAP-A holoenzyme and linear dsDNA template were incubated at 37oC for 
10mins. Reactions were initiated by adding 2.5 μl of a substrate mixture containing 200 GpU, 
UTP, and 32P radiolabeled UTP and incubating at 37oC for 10 minutes to allow for production of 
a 3 nt product in 20 μl reactions that included a final concentration of 2 μM RbpA, 100 nM M. 
tuberculosis RNAP-A holoenzyme, 10 nM linear dsDNA template, 1 mM DTT, 0.1 mg/ml BSA 
(NEB), 200 μM GpU, 20 μM UTP, 0.2 μl of 32P radiolabeled UTP, 75 mM NaCl, 10.1 mM 
MgCl2, 2 μM ZnCl2, 18 mM Tris pH 8.0, 0.01 mM EDTA, 5% glycerol and 0.1 mM -
mercaptoethanol. Reactions were stopped with 2X formamide stop buffer (98% [vol/vol] 
formamide, 5 mM EDTA and 0.05% w/v bromophenol blue). Reaction products were resolved 
by 22% polyacrylamide-urea gel electrophoresis and exposure to autoradiography film. Products 
were quantified using ImageJ.  
Multi-round in vitro transcription. RbpA , linear DNA PCR-amplified from the pMSG434 
plasmid containing the M. tuberculosis rrnAP3 promoter including positions -39 to +4, and 
NTPs (2 mM ATP, 2 mM CTP, 0.1 mM UTP, 4 mM GTP and 0.2 μl per reaction of 32P 
radiolabeled GTP) were mixed to a final volume of 23 μl. Reactions were initiated with the 
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addition of M. tuberculosis RNAP-A holoenzyme and incubated for 1 hour at 37oC. The 
reactions included a final concentration of 2 μM RbpA, 0.8 nM of template DNA, 40 nM M. 
tuberculosis RNAP-A holoenzyme, 1 mM DTT, 0.1 μg/ml BSA, 200 μM ATP, 200 μM CTP, 
10 μM UTP, 400 μM GTP, 0.2 μl of 32P labeled GTP, 75 mM NaCl, 10.1 mM MgCl2, 2 μM 
ZnCl2, 18 mM Tris pH 8.0, 0.01 mM EDTA, 5% glycerol and 0.1 mM -mercaptoethanol. 
Reactions were stopped with 2X formamide stop buffer (98% [vol/vol] formamide, 5 mM EDTA 
and 0.05% w/v bromophenol blue). Reaction products were resolved by 10% polyacrylamide-
urea gel electrophoresis, exposure to phosphoimager screen and imaged using an Amersham 
Typhoon scanner.  
Fidaxomicin Dose Response Curve. RbpA diluted in RbpA storage buffer, M. tuberculosis 
RNAP-A holoenzyme diluted in holoenzyme storage buffer and 10X transcription buffer were 
mixed to a final volume of 14.5 μl. Fidaxomicin diluted in DMSO to a concentration of 2000 
μM, 200 μM, 20 μM, 2 μM and 0.2 μM or DMSO was added to the reaction mixtures and the 
reaction mixtures were incubated at 37oC for 10mins. The linear dsDNA template containing the 
M. tuberculosis rrnAP3 promoter as described in the 3-nucleotide in vitro transcription section, 
was added to reaction mixtures and incubated at 37oC for 15mins. Reactions were initiated by 
adding GpU dinucleotide, UTP and 32P radiolabeled UTP to allow for production of a 3 nt 
product in a 20 μl mixtures including 2 μM RbpA, 100 nM M. tuberculosis RNAP-A 
holoenzyme, 10 nM linear dsDNA template, 1mM DTT, 0.1% mg/ml BSA (NEB), 200 μM 
GpU, 20 μM UTP, 0.2 μl of 32P radiolabeled UTP, 75 mM NaCl, 10.1 mM MgCl2, 2 μM ZnCl2, 
18 mM Tris pH 8.0, 0.01 mM EDTA, 5% glycerol, 0.1 mM -mercaptoethanol and either 100 
μM, 10 μM, 1.0 μM, 0.1 μM, 0.01 μM or 0 μM of fidaxomicin. Reactions were stopped with 2X 
formamide stop buffer and resolved by 22% polyacrylamide-urea gel electrophoresis and 
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exposure to autoradiography film. Products were quantified using ImageJ and IC50 values were 
calculated using Prism software by four parameter normalized (maximum = 100% and minimum 
= 0%) nonlinear regression fitting using logarithmic normalization of the Fdx concentrations 
included in these experiments. 
Results 
RbpA E17 and R10 synergize to promote Fdx activity against M. tuberculosis RNAP-σA in 
vitro 
 
In vitro assays that monitor the production of a 3 nucleotide (nt) product as a proxy of 
RPo stability have shown that addition of Fdx to M. tuberculosis RNAP-σ
A holoenzymes reduces 
the amount of RPo formed following the subsequent addition of NTPs and a DNA template 
harboring the M. tuberculosis rrnAP3 promoter 67(Figure 1a and 1b). Addition of wild-type 
(WT) RbpAMtb (RbpAMtb
WT) to the RNAP-σA holoenzymes increases the sensitivity of the 
RNAP-σA holoenzyme to Fdx in this assay, and this is dependent on the presence of the NTT 
(amino acids 1-25 in RbpAMtb, deleted in the RbpAMtb
26-111 mutant)67(Figure 1a and 1b). 
Structural studies predicted that the NTT contributes contacts with Fdx when the antibiotic is 
bound to the M. tuberculosis RNAP-σA holoenzyme (PDB: 6BZO), specifically through a water 
mediated interaction between RbpA E17 and Fdx (Figure 1c)67. To determine whether the 
predicted interaction between Fdx and RbpA E17 underpins NTT-dependent Fdx activity, we 
calculated the concentration of Fdx to inhibit 50% of RPo (IC50) formed by M. tuberculosis 
RNAP-σA on the rrnAP3 promoter in the presence of RbpAMtb
WT versus an RbpAMtb
E17A mutant 
protein. The activity of Fdx against the M. tuberculosis RNAP-σA in the presence of RbpAMtb
E17A 
was nearly equal to Fdx activity against the M. tuberculosis RNAP-σA in the presence of 
RbpAMtb
WT, indicating that the contribution of RbpA E17 to the interaction between Fdx and 
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RNAP-σA is not required for Fdx activity against the M. tuberculosis RNAP-σA (Figure 1a and 
1b).  
The structure in Boyaci et al. also highlights potential van der Waals interactions between 
RbpA R10 and Fdx in the RNAP-A holoenzyme bound to double stranded forked DNA (PDB: 
6BZO)67(Figure 1c), however, given the distance between RbpA R10 and Fdx, one would 
predict this to be a weak interaction. In a separate structure of RbpA bound to M. tuberculosis 
RNAP-σA in complex with two double stranded forked DNA molecules that mimics the RPo 
(PDB: 6C04), the RbpA R10 positively charged side chain is positioned within 2.4 angstroms of 
the negatively charged side chain of σA3.2 D441, forming a polar interaction 
67(Figure 1d). Fdx 
activity against E. coli RNAP-σ70 holoenzyme lacking σ703.2 is attenuated approximately 20-fold 
134, indicating the σ703.2 contributes to Fdx inhibition of the E. coli RNAP and if RbpA R10 
interacts with σ703.2, this may also affect Fdx activity. To examine whether RbpA R10 
contributes to M. tuberculosis RNAP-σA Fdx sensitivity, we measured Fdx IC50s against the M. 
tuberculosis RNAP-σA in the presence of RbpAMtb
R10A. Similar to the RbpAMtb
E17A mutant, we 
observed no change in Fdx IC50s against the M. tuberculosis RNAP-σA in the presence of 
RbpAMtb
R10A compared to RbpAMtb
WT (Figure 1a and 1b), indicating that the R10 residue is not 
required for RbpA NTT dependent Fdx activity. To determine the effect of disrupting the 
contacts made by the both RbpA E17 and R10, we measured the Fdx IC50 against M. 
tuberculosis RNAP-σA in the presence of RbpAMtb
R10A/E17A. Mutating both the R10 and E17 
residues resulted in an approximately three-fold increase in the Fdx IC50 compared to 
RbpAMtb
WT (Figure 1a and 1b), indicating that loss of one of these residues increases the 
importance of the other for Fdx activity. However, the IC50 of Fdx in the presence of 
RbpAMtb
R10A/E17A is still five-fold lower than that of RbpAMtb
26-111, the ΔNTT mutant, and not 
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significantly different compared to RbpAMtb
WT, suggesting that additional mechanisms contribute 
to NTT-dependent Fdx activity.  
The RbpA CD and conserved residues in the BL and SID do not affect Fdx activity against 
the M. tuberculosis RNAP-σA in vitro 
 To further investigate the mechanism of RbpA NTT-dependent Fdx activity, we 
identified conserved residues within the M. tuberculosis RbpA NTT (R4, L6, R7, and S15) that 
were positioned near various functional domains in the RNAP-σA holoenzyme to mutagenize and 
monitor for effects on Fdx activity in vitro (PDB: 6BZO)(Figure 2a and 2b). RbpA R4 is 
positioned near the RNAP  Sw3, RbpA L6 is positioned near the RNAP β’ lid, RbpA R7 is 
positioned near σA3.2, and RbpA S15 is positioned near the RNAP β’ ZBD. We evaluated the role 
of the positively charged side chains of R4 and R7 by substituting these amino acids with either 
alanine or glutamate, assessed the length of the hydrophobic L6 side chain by substituting the 
leucine with alanine, and determined the role of the polar S15 side chain by substituting the 
serine with alanine. Addition of any of these RbpA mutants to the in vitro assays for Fdx inhibition of 
RPo resulted in nearly identical IC50s as observed in the presence of RbpAMtb
WT (Figure 2c), 
demonstrating that none of these residues are required for NTT-dependent Fdx activity in vitro. 
 Until this point, the NTT is the only RbpA domain that has been investigated for effects 
on Fdx activity. Although the RbpA CD, BL, and SID are not predicted to directly interact with 
Fdx, we reasoned that RbpA binding to the RNAP-σA holoenzyme could impact Fdx activity 
through an indirect mechanism, such as altering RNAP clamp dynamics. Fdx only binds to the 
open clamp conformation that exists in the RNAP closed promoter complex (RPc) and locks the 
RNAP in the open clamp conformation. The closing of the clamp that occurs during RPo restricts 
the volume of the Fdx binding cleft, making Fdx unable to bind RPo. To determine whether the 
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RbpA CD affects Fdx activity against the M. tuberculosis RNAP-σA, we measured the IC50 of 
Fdx inhibition of M. tuberculosis RNAP-σA RPo in the presence of RbpAMtb
72-111, which lacks 
both RbpA NTT and CD. Deletion of the RbpA NTT and CD resulted in an IC50 similar to a 
deletion of the NTT alone (Figure 1b and 2c), indicating that the presence of the RbpA CD does 
not affect Fdx activity against M. tuberculosis RNAP-σA in vitro. We then determined whether 
the RbpA BL and SID play a role in Fdx activity against the M. tuberculosis RNAP-σA in vitro 
by measuring Fdx activity against M. tuberculosis RNAP-σA in the presence of RbpAMtb
R79A or 
RbpAMtb
R88A, mutations that have been shown to weaken the activities of the BL or SID, 
respectively 22,106,125. Fdx activity against M. tuberculosis RNAP-σA in the presence of 
RbpAMtb
R79A or RbpAMtb
R88A was similar to reactions containing RbpAMtb
WT, demonstrating that 
mutating residues critical for RbpA BL and SID activity does not affect Fdx activity in vitro in 
this assay (Figure 1b and 2d). 
Multiple RbpA domains and CarD impact Fdx activity in vivo 
 Previous work showed that truncation of the RbpA NTT decreases Fdx activity both in 
vitro and in vivo in Mycobacterium smegmatis67. Based on the in vitro results above, we 
expected that only M. smegmatis expressing RbpAMtb
26-111 and RbpAMtb
72-111 would be more 
resistant to Fdx than M. smegmatis expressing RbpAMtb
WT. To investigate the effect of mutations 
in RbpA on Fdx sensitivity in vivo, we used a strain we previously engineered that expresses 
rbpAMtb
WT at the attB site of M. smegmatis and has the endogenous rbpA gene deleted 125. We 
then attempted to replace the rbpAMtb
WT gene at the attB site in M. smegmatis with alleles 
encoding each of the RbpA mutants studied in Figures 1 and 2 using a gene swapping method 
95,111,125. We have previously used this approach to generate a M. smegmatis strain expressing 
rbpAMtb
72-111, which has a deletion of both the NTT and CD, as its only rbpA allele 125. However, 
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we were unable to generate a viable strain expressing rbpAMtb
26-111, which deletes only the NTT, 
in place of rbpAMtb
WT. In contrast, we were able to replace the rbpAMtb
WT allele with the M. 
smegmatis allele rbpAMsm
28-114, which has previously been used to study the NTT in M. 




72-114 strains also exhibited a slow growth 
phenotype (Figure 3a), confirming that while the NTT and CD are not required for viability in 
M. smegmatis, they are important domains for RbpA activity. Using the gene swapping 
approach, we found that all of the RbpA NTT point mutants could support viability in M. 





exhibited significantly decreased growth rate compared to RbpAMtb
WT in LB media (Figure 3a). 
The slower growth rates in these RbpA point mutants suggests that the residues targeted may 
contribute to NTT activity in M. smegmatis.  
 To examine the Fdx sensitivity of each M. smegmatis strain, we used a zone of inhibition 
assay, similar to previous studies 67,94. By spreading approximately 2.5 × 108 colony forming 
units (CFUs) of bacteria on an agar plate and spotting 10 μl of 100, 250, or 500 μM Fdx 
dissolved in dimethyl sulfoxide (DMSO) onto a disk placed onto the plate, the bacteria form a 
lawn after incubation at 37oC for 2 days and a zone absent of bacterial growth indicates growth 
inhibition by Fdx. DMSO had no effect on M. smegmatis growth in this assay and did not 
generate a zone of clearing on its own, whereas incubation of M. smegmatis with Fdx resulted in 
growth inhibition (Figure 3b). We compared the radii of the zones of inhibition formed on each 
M. smegmatis mutant with Fdx and reproduced previous findings that deletion of the RbpA NTT 
results in resistance to Fdx in vivo (RbpAMtb
72-111, RbpAMsm
28-114 and RbpAMsm
72-114 mutants in 




R10A/E17A mutant was not more resistant to Fdx in vivo, which is discordant 
from the in vitro findings where we observe a non-significant but trending decrease in 
RbpAMtb
R10A/E17A sensitivity to Fdx compared to RbpAMtb
R10A/E17A (Figure 1b, Figure 3c and 
supporting information 1). In addition, the RbpAMtb
R4A and RbpAMtb
R7A mutants showed 
increased sensitivity to Fdx at all concentrations tested and the RbpAMtb
R4E mutant displayed 
increased resistance when 100 μM Fdx was spotted on the disks, despite these mutants exhibiting 
no change in Fdx IC50 in vitro (Figure 2c and Figure 3b and 3c). The rest of the NTT 
mutations did not affect Fdx sensitivity in M. smegmatis (Figure 3c and supporting 
information 1). Strikingly, the M. smegmatis RbpAMtb
R79A and RbpAMtb
R88A mutants, which 
have decreased affinity for DNA and the σ factor, respectively, were significantly more sensitive 
to Fdx treatment (Figure 3b and 3c). These in vivo data highlight other contributors to RbpA’s 
effect on Fdx activity that exist in the bacteria but are not recapitulated in the in vitro assay.  
RbpA stabilizes RNAP-σA RPo in vitro, which requires binding of the SID to the RNAP-
σA holoenzyme and binding of the BL to the DNA. In contrast, the NTT antagonizes RbpA’s RPo 
stabilizing activity. Accordingly, RbpAMtb
R79A and RbpAMtb
R88A decrease RPo stability and 
RbpAMtb
26-111 increases RPo stability in vitro. These effects on RPo stability follow the same 
pattern as observed with Fdx sensitivity in vivo, where the RbpAMtb
R79A and RbpAMtb
R88A mutants 
are more sensitive, and the RbpAMsm
28-114 mutant is more resistant (Figure 3b and 3c). RPo 
formation involves closing of the RNAP clamp, which is predicted to block binding of Fdx to the 
RNAP and could explain this pattern of Fdx sensitivity observed in the RbpA mutants in vivo. 
CarD is another essential transcription factor in mycobacteria that functions to stabilize RPo. We 
reasoned that if RPo stability was linked to Fdx activity in vivo, then M. smegmatis strains 
expressing the CarDMtb
R25E mutant that has a weaker affinity for the RNAP and is defective in 
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stabilizing RPo would be more sensitive to Fdx than M. smegmatis expressing CarDMtb
WT. 
Indeed, when we performed the zone of inhibition assays on these strains, we found that the 
R25E mutation in CarD also increased the sensitivity of M. smegmatis to Fdx (Figure 3d and 
3e), possibly in part due to a contribution of RPo stability to Fdx activity in vivo. In addition, Fdx 
has been shown to decrease the affinity of CarD to RNAP in vitro, which may also contribute to 
the increased susceptibility of the CarDMtb
R25E mutant. 
Mutation of residues within the RbpA NTT positioned near the RNAP β’ lid, RNAP σA3.2, 
and the RNAP ZBD increase RPo stabilization by RbpA 
In contrast to the RbpA BL and SID domains that promote RPo stability in vitro, the 
RbpA NTT and CD antagonize RPo stability 
125, but it is unknown how the NTT and CD impart 
this effect on the RNAP-σA holoenzyme. To gain insight into this area, we examined how the 
conserved residues within the M. tuberculosis RbpA NTT, contributed to the effect of the NTT 
on RPo stability in the 3 nt transcription assay. As previously reported 
125, addition of RbpAMtb
26-
111 or RbpAMtb
72-111 to M. tuberculosis RNAP-σA and the rrnAP3 promoter increases RPo stability 
compared to RbpAMtb
WT, although the RbpAMtb
26-111 did not reach statistical significance in this 
assay (Figure 4a and 4b). Alanine substitutions in RbpA L6, predicted to be positioned near 
hydrophobic residues in the RNAP β’ lid, or RbpA R7, positioned near σA3.2, resulted in a higher 
level of RPo stability compared to RbpAMtb
WT (Figure 4a and 4b). In addition, mutation of 
RbpA S15 or E17, two residues positioned near the RNAP β’ ZBD, also resulted in increased 
RPo stability compared to RbpAMtb
WT. Conversely, glutamate substitution for RbpA R4, 
positioned near RNAP β Sw3, resulted in a lower level of RPo stability compared to RbpAMtb
WT. 
These data suggest that the NTT could antagonize RNAP-σA RPo stability on the rrnAP3 
promoter through contacts with RNAP β’ lid, σA3.2 and β’ ZBD while also making other 
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interactions with RNAP β Sw3 that support RNAP-σA RPo stability. Notably, although the 
mutations in RbpA L6, R7, S15, and E17 resulted in increased RPo, these mutations did not lead 
to decreased sensitivity to Fdx, uncoupling the effects of the RbpA NTT on RPo stability and Fdx 
sensitivity (Figure 4c).   
The RbpA NTT promotes M. tuberculosis RNAP-σA full-length transcription from the M. 
tuberculosis rrnAP3 promoter 
RbpA is essential in mycobacteria and required to stabilize RNAP-σA and RNAP-σB RPo 
in vitro 107–109,125. Assuming that the ability to stabilize RPo is linked to RbpA’s essential role in 
mycobacteria, it remains unknown how mycobacteria would benefit from RbpA NTT 
antagonism of RPo, but suggests that there is a significant consequence of NTT activity on 
transcription. To determine the impact of the NTT on full length transcript production, we 
performed multi-round in vitro transcription assays comparing M. tuberculosis RNAP-σA full-
length transcript production from the M. tuberculosis rrnAP3 in the presence of either 
RbpAMtb
WT or RbpAMtb
26-111. Similar to previous reports 108, we found that addition of RbpAMtb
WT 
resulted in increased full length transcript production from rrnAP3 (Figure 5). Deletion of the 
NTT attenuated full length transcript production (Figure 5), despite increasing RPo
 stability 
compared to RbpAMtb
WT (Figure 4). These data suggest that the NTT destabilization of RPo 
facilitates transition of the RNAP through intermediate states that we have previously identified 
during transcription initiation 69. 
Discussion 
Prior studies on RbpA have focused almost exclusively on the SID interaction with σ 
factor and the BL interaction with DNA, leaving the NTT and CD largely uncharacterized. 
Structural studies have provided tremendous insight into the potential interactions between the 
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NTT and CD with multiple RNAP-σA holoenzyme domains10,67,106. Herein we probe the roles for 
these interactions in RbpA activity through directed genetic mutation of conserved residues 
within the NTT. We test the prediction that RbpA R10 and E17 contribute contacts with the 
antibiotic Fdx that are important for its activity against M. tuberculosis RNAP-σA. We find that 
in vitro, mutation of both residues affects Fdx activity against the M. tuberculosis RNAP-σA 
(Figure 1a and 1b), however, it is still not clear whether RbpA R10 and E17 promote RbpA 
NTT-dependent Fdx activity through direct interaction with Fdx or through an alternative 
mechanism. Maintenance of partial Fdx activity against M. tuberculosis RNAP-σA bound by 
RbpAMtb
R10A/E17A in vitro indicates that additional RbpA NTT residues or perhaps the entire 
structural domain mediate RbpA NTT-dependent Fdx activity. In vivo, the RbpAMtb
R10A/E17A 
mutant did not affect Fdx sensitivity in M. smegmatis, suggesting that RbpA impacts Fdx activity 
independent of its contacts with the antibiotic. In support of this interpretation, we identify 
several RbpA NTT point mutations that alter M. smegmatis sensitivity to Fdx in vivo (Figure 3b 
and 3c) despite being in residues not expected to interact directly with Fdx. In addition, the 
substitution of R88A that weakens RbpA interaction with the RNAP in vivo 125, and thus would 
be expected to decrease M. smegmatis sensitivity to Fdx since less RbpA would be associated 
with RNAP-σA, significantly increased M. smegmatis sensitivity to Fdx. This suggests that the 
loss of RbpA activity conferred by the R88A substitution has a greater impact on Fdx sensitivity 
than the weakened RbpAMtb
R88A-RNAP interaction. The experiments herein shed new light on 
the complex mechanism of RbpA mediated Fdx activity. 
Although it is unclear how the different RbpA mutants alter M. smegmatis sensitivity to 




R25E mutants that decrease RPo
 stability increase M. 
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smegmatis sensitivity to Fdx. Similarly, truncations that increase RbpA RPo stabilizing activity, 
RbpAMtb
26-111 and RbpAMtb
72-111, decrease M. smegmatis sensitivity to Fdx. However, analysis of 
RbpA NTT point mutants yielded no correlation between RPo stability and M. smegmatis 
sensitivity to Fdx, making it unclear what role the equilibrium between RPc and RPo plays in 
determining M. smegmatis sensitivity to Fdx.  
Our assays revealed differences in the effects of RbpA mutants on Fdx sensitivity in vitro 
compared to in vivo. These discrepancies may be due in part to the limited scope of the in vitro 
assay used here and in previous studies to probe Fdx activity 67, where Fdx is added to RbpA and 
RNAP-σA holoenzyme in the absence of DNA. Whereas in the cell, RNAP-σA holoenzyme could 
be bound to DNA prior to Fdx binding. This limitation may bias the in vitro assay towards 
identifying the factors that affect Fdx binding to free RNAP-σA holoenzyme complex. As such, 




R7A) could result from these RbpA NTT residues being 
important for Fdx binding to DNA bound holoenzyme rather than free RNAP. This notion is 
supported by a comparison of RbpA NTT interactions with Fdx bound to free M. tuberculosis 
RNAP (PDB: 6C06) and Fdx bound to M. tuberculosis RNAP in complex with DNA (PDB: 
6BZO)67. In the absence of DNA, the RbpA NTT is positioned closer to RNAP ’ ZBD, RNAP 
’ lid and RNAP A 3.2 in what could be described as a more compact structure compared to the 
DNA bound complex. The more compact structure results in several polar interactions between 
RbpA and the RNAP-σA holoenzyme that do not occur in the presence of DNA. The differences 
between how RbpA interacts with DNA bound versus unbound RNAP-σA holoenzyme highlight 
the need to biochemically characterize Fdx activity against not just free RNAP but the additional 
RNAP complexes that exist within the bacteria. The in vitro assay also excludes other RNAP 
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holoenzymes and RNAP interacting proteins present in the bacteria that may affect Fdx activity 
in vivo.  In addition to these direct effects on RNAP, truncation of the RbpA NTT results in 
global dysregulation of gene expression in M. smegmatis 106,125, which could also affect 
sensitivity to Fdx. 
RbpA has been shown to increase RPo stability and based on recent modeling 
135, we 
hypothesize that this regulatory mechanism can be capable of transcriptional activation and 
repression. In this study, we find that RbpA increases full length transcript production from the 
M. tuberculosis rrnAP3 promoter. The RbpA NTT antagonizes the ability of RbpA to stabilize 
M. tuberculosis RNAP-σA RPo while decreasing at least one rate constant in the RPc to RPo 
transition 125. At the rrnAP3 promoter, NTT antagonism of RPo stability results in increased full 
length transcript production. Mechanistically, one of the ways that RbpA NTT antagonism of 
RPo stability may result in an increase in transcriptional flux is through enhancing the rate of 
promoter escape.  Loss of RbpA NTT antagonism of RPo stability may slow the rate of promoter 
escape and decrease transcriptional flux, though the role of RbpA NTT in promoter escape has 
not yet been determined 69. Alternatively, the RbpA NTT could impact one of the intermediate 
steps between RPo formation and promoter escape, which we have also demonstrated to be 
impacted by RbpA in vitro 69 Given that the RbpA NTT is predicted to contact multiple 
functional domains of the RNAP-σA holoenzyme that have been shown to affect various steps of 
transcription initiation (as described in the introduction), the mechanistic basis for NTT 
regulation of RbpA activity and physiological consequences on the bacteria are likely complex 
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Figure 1. RbpA E17 and R10 synergize to promote fidaxomicin inhibition of M. tuberculosis RNAP-σA 
holoenzyme activity in vitro 
a. Representative gels showing Fdx (0 μM, 0.01 μM, 0.1 μM, 1.0 μM, 10 μM, 100 μM) 






26-111 from a 
linear dsDNA template containing positions -80 to +70 of M. tuberculosis rrnAP3 
(relative to the +1 transcription start site). 
b. Dose response curves of the results shown in (A). The curves are generated from at least 
four replicates from at least two different experiments. Percent inhibition at each Fdx 
concentration included in the plots is the mean +/- SEM. The IC50 for each replicate was 
calculated by non-linear regression analysis with four parameter fitting of log 
transformed Fdx concentration versus normalized response, with the mean IC50 and 95% 
confidence interval listed in the table. Statistical comparisons were performed with one-
way analysis of the variance (ANOVA) and Tukey’s multiple comparison test. All 
comparisons to RbpAMtb
WT were included in the analysis but only statistically significant 
comparisons are indicated in the figure; **, P < 0.01; ***, P < 0.001. 
c. Structural modeling of Fdx binding pocket on the RbpA bound M. tuberculosis RNAP-σA 
from PDB structure 6BZO. Fdx and RNAP residues involved in the RNAP-Fdx binding 
interface are shown with PyMol stick representation while the rest of the structure is 
shown with PyMol cartoon representation. Polar interactions are indicated by red-dashed 
lines and potential Van der Waals interactions are shown as gray lines. 
d. Structural modeling of RbpA bound M. tuberculosis RNAP-σA from PDB structure 6C04. 
RbpA R10 and RNAP σA D441 are shown with PyMol stick representation while the rest 
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of the structure is shown with PyMol cartoon representation. The polar interaction 
















Figure 2. The RbpA CD, BL, and SID do not affect fidaxomicin activity against the M. tuberculosis 
RNAP-σA in vitro 
a. Alignment of RbpA. Conserved RbpA NTT residues targeted in this analysis are 
indicated by an asterisk and the four RbpA structural domains are indicated. 
b. Structural modeling of RbpA NTT interactions with the RNAP from PDB structure 
6C04. RbpA NTT residues targeted in this analysis are shown with PyMol stick 
representation while the rest of the structure is shown with PyMol cartoon representation. 
Zoom in views of areas (a) – (f) show RbpA R4, L6A, R7A, R10, S15 and E17, 
respectively, and the RNAP residues located near these RbpA NTT residues or predicted 
to make polar interactions in PyMol are shown in stick representation.  
c. and d. Dose response curves of Fdx (0 μM, 0.01 μM, 0.1 μM, 1.0 μM, 10 μM, 100 μM) 












R88A from linear dsDNA template 
containing -80 to +70 positions of M. tuberculosis rrnAP3 relative to the +1 transcription 
start site. The curves are generated from at least four replicates from at least two different 
experiments. Percent inhibition at each Fdx concentration included in the plots is the 
mean +/- SEM. The WT data from Figure 1 is included in C and D because the 
experiments were run simultaneously with the same controls. IC50 values and statistics 
were calculated as done in Figure 1. All comparisons to RbpAMtb
WT were included in the 
analysis but only statistically significant comparisons are indicated in the figure; *, P < 








Figure 3. Multiple RbpA domains and CarD impact Fdx activity in vivo 

























c. The results are plotted showing the mean ± SEM from at least two experiments with three 
replicates at 0 μM, 100 μM, 250 μM and 500 μM Fdx. Statistical significance was 
analyzed by analysis of the variance (ANOVA) and Tukey’s multiple comparison test. *, 
P < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ns, not significant. All 
comparisons were included in the analysis but only statistically significant comparisons 
are indicated in the figure.   
d. ZOI by Fdx on bacterial lawns of M. smegmatis expressing either CarDMtbWT or 
CarDMtb
R25E.  
e. The results are plotted showing the mean +/- SEM from three experiments with three 
replicates at 0 μM, 100 μM, 250 μM and 500 μM Fdx. Statistical significance was 











Figure 4. Mutations of residues in the RbpA NTT increases RPo stability  














linear dsDNA template containing positions -80 to +70 of M. tuberculosis rrnAP3 
relative to the +1 transcription start site.   
b. Ratio of transcript produced as compared to the average of RbpAMtbWT replicates included 
on the same gel. At least two replicates from three different experiments for a total of six 
replicates were included for each RbpAMtb variant in the analysis. Results are plotted as 
individual values with the mean +/- SEM shown. Statistical significance of differences 
was determined by ANOVA and Tukey’s multiple comparison test. *, P < 0.05; **, P < 
0.01; ****, P < 0.0001. All comparisons to RbpAMtb
WT were included in the analysis, but 
only statistically significant comparisons are indicated in the figure.  
c. Overview of the effect of RbpA mutants on Fdx IC50 (Figs. 1 and 2), Fdx ZOI (Fig. 3), 
and RPo stability (Fig. 4) as compared to RbpAMtb
WT. NS indicates not significantly 
different. For Fdx IC50 column; dark green = significantly increased IC50 compared to 
RbpAMtb
WT. For Fdx ZOI column; light green = significantly less sensitive to Fdx 
compared to RbpAMtb
WT at one Fdx concentration; dark green = significantly less 
sensitive to Fdx compared to RbpAMtb
WT at more than one Fdx concentration; dark red = 
significantly more sensitive to Fdx compared to RbpAMtb
WT at more than one Fdx 
concentration. For RPo stability column; dark green = significantly increased RPo 
compared to RbpAMtb






























Figure 5. RbpA NTT promotes M. tuberculosis RNAP-σA full-length transcription on the M. 
tuberculosis rrnAP3 promoter.  
a. Gel of full-length transcript production by M. tuberculosis RNAP-σA alone or in complex 
with RbpAMtb
WT or RbpAMtb
26-111 from the M. tuberculosis rrnAP3 promoter on a linear 
dsDNA template containing positions -39 to +4 of M. tuberculosis rrnAP3 relative to the 
+1 transcription start site.  
b. Mean ratios +/- SEM of the amount of transcript produced by each sample as compared 
to the average of no factor added samples. Statistical significance was analyzed by 














Supplemental figure 1. ZOI from 0 μM, 100 μM, 250 μM and 500 μM Fdx on bacterial lawns 





































Chapter 4: M. smegmatis σB activates transcription in a RbpA independent 
manner during logarithmic growth and is made synthetically essential by loss 






















 RbpA interacts with M. tuberculosis’s essential housekeeping A and the structurally 
similar but non-essential B. Most studies characterizing B in M. tuberculosis have focused on 
B activities when various stresses are imposed on M. tuberculosis. From these studies, it is well 
understood that B is critical for M. tuberculosis stress tolerance. However, B activities in other 
mycobacterial species during stress or logarithmic growth have not yet been characterized. 
Furthermore, to what extent RbpA alters B activities under various growth conditions in M. 
tuberculosis or other mycobacteria species is still an open question. In vitro analyses of the 
RbpA-B complex show that RbpA increases B activities at housekeeping promoters, 
suggesting that RbpA mediates functional overlap between A and B. In this study we 
interrogate the RbpA dependent and independent B regulon in M. smegmatis, a soil dwelling 
fast growing mycobacterial species, during logarithmic growth and find that the B regulon is 
almost entirely RbpA independent. Our data also suggests that during logarithmic growth B 
activates transcription of a cohort of genes that if translated are short and highly charged. We 
determine that point mutations in RbpA, which in vitro blunt RbpA RPo stabilizing activity and 
in vivo slow M. smegmatis growth, alter sigB from a non-essential gene to a synthetically 
essential gene.  
Introduction  
 M. tuberculosis B is a non-essential housekeeping like  factor and is homologous to E. 
coli’s stationary phase  factor, S. In E. coli, S serves as a general stress response  factor that 
accumulates in response to multiple types of stress through a complex regulatory network of 
small RNAs 136. One of the defining features of the E. coli S general stress response is the 
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altered expression of gene products seemingly unrelated to whatever stress that triggered the 
general stress response. The role of B in M. tuberculosis is not as well-defined as that of S in 
E. coli but studies that have investigated sigB expression or the impact of altering sigB 
expression on M. tuberculosis replication during various stresses lend support for B serving as a 
general stress response  factor in M. tuberculosis. Expression of sigB is increased when M. 
tuberculosis enters stationary phase, lacks nutrients during starvation, is exposed to hypoxia, heat 
or cold temperatures or is treated with thioridozine 137–139. Deletion of sigB increases M. 
tuberculosis sensitivity to hypoxia, cell surface stress, iron starvation and treatment with 
antibiotics including rifampicin, p-aminosalicylic acid, sulfamethoxazole and ethambutol 140–143.  
Other studies that have interrogated how sigB transcription is regulated also support the 
notion that B acts a general stress response  factor. Specifically, sigB is expressed from two 
promoters, the first promoter is activated by the stress-inducible  factors, E, H and L as well 
as the MprAB two-component system and the second promoter is regulated by another stress-
inducible  factor, F 144–146. In conformity with the E. coli S paradigm of a general stress 
response, this data suggests that B protects M. tuberculosis from a broad array of stresses rather 
than a specific stress. 
 Despite the ample evidence that B is pivotal to M. tuberculosis survival during stress, 
other data suggest that B is not a general stress response  factor and instead functions more 
like a housekeeping  factor (A in M. tuberculosis or 70 in E. coli). This model is supported by 
the observation that deletion of sigB does not diminish the survival of M. tuberculosis in 
macrophages or murine tissues, which would be expected if B is important for protection 
against the myriad of stresses imposed on the bacterium during infection 140. Other evidence 
suggesting that B is functionally more similar to A or 70 than S is the finding that sigB is 
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expressed at high levels that are comparable to sigA during logarithmic growth in M. 
tuberculosis. This is distinct from the expression pattern of rpoS (gene nomenclature for S) in E. 
coli where rpoS levels are much lower compared to rpoD (gene nomenclature for 70) during 
logarithmic growth 137,147. Furthermore, ChIP-seq analysis to define the B regulon in M. 
tuberculosis during logarithmic growth found that B is localized to the promoters of many 
housekeeping genes 143. 
 Another feature that differentiates M. tuberculosis B from E. coli S is B interaction 
with the essential protein RbpA, which is not encoded by E. coli. The housekeeping like 
behavior of B is enhanced when in complex with RbpA. This was first demonstrated when 
RbpA was shown to increase B-holoenzyme transcription of the housekeeping sigA promoter 
108. How RbpA allows the B-holoenzyme to activate transcription at housekeeping promoters 
has not yet been fully elucidated but some details have emerged indicating that RbpA allows the 
B-holoenzyme to overcome a deficiency at housekeeping promoters with a ‘minimal’ extended 
-10 element sequence 148,149. Approximately 70% of M. tuberculosis’s promoters have a 
guanosine at positions -13 or -14 relative to the +1 TSS, which in addition to -11A and -7T 
within the -10 element, is the minimal housekeeping promoter sequence sufficient for A-
holoenzyme activation that can occur without RbpA 149. In contrast, activity of the B-
holoenzyme at this minimal housekeeping promoter requires RbpA 108,149.  
 Collectively, the work thus far suggests that M. tuberculosis B could be important for a 
stress response program that was not captured in the macrophage or murine infection models 
while also contributing to the transcription of M. tuberculosis’s housekeeping genes in a RbpA 
dependent manner. However, there are still many questions that need to be answered regarding 
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B function in M. tuberculosis and other mycobacterium species. First, the differences between 
the role of B in M. tuberculosis and S in E. coli raise the question of whether there are 
additional B functions that can be discovered through studying B homologs in other bacterial 
species. Second, it is unclear whether B only functions in a RbpA dependent manner or whether 
B also performs RbpA independent functions. Lastly, it is not yet clear whether RbpA-bound B  
and RbpA-bound A holoenzymes carry out overlapping or distinct  functions in vivo. 
 In this study we define the B regulon in M. smegmatis during logarithmic growth by 
examining the transcriptome of M. smegmatis ΔsigB and determine that this regulon consists of 
approximately 600 genes. Among these 600 genes, we highlight a novel cohort of transcripts that 
if translated would be short and highly charged proteins. We compare the transcriptome of M. 
smegmatis ΔsigB to a that of a M. smegmatis strain with a point mutation in RbpA, R88A, which 
weakens RbpA binding to A and B, and we find little overlap between the transcriptomes 
suggesting that the B regulon during logarithmic growth in M. smegmatis occurs through a 
RbpA independent mechanism. We find that sigB is synthetically essential in the genetic context 
of RbpA point mutations including R88A, as well as R79A that weakens RbpA interactions with 
the DNA phosphate backbone during the RNAP open promoter complex (RPo).  
Experimental Procedures 
Media and bacterial strains. All M. smegmatis strains were derived from mc2155 and grown at 
37°C in LB medium supplemented with 0.5% dextrose, 0.5% glycerol, and 0.05% Tween 80 
(broth). The M. smegmatis merodiploid strain was constructed by integrating pMSG430-
rbpAMtb
WT into the attB site of mc2155. The M. smegmatis merodiploid strain was transformed 
with pDB88, with homology to mc2155 nucleotides 3928650 to 3929246 and 3929589 to 
3930405, to replace the endogenous rbpA, using two-step allelic exchange as described 
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previously 112, thus generating ΔrbpA::tet-rbpAMtb
WT, which was named csm275. Csm275 was 
transformed with pDB19-rbpAMtb
WT to replace the pMSG430-rbpAMtb
WT construct at the attB site 
of the M. smegmatis ΔrbpA attB::tet-rbpAMtb
WT strain using gene swapping as described 
previously 111. The transformants were selected with zeocin, and loss of the pMSG430-
rbpAMtb
WT construct was confirmed by verifying their inability to grow in the presence of 
kanamycin. The M. smegmatis ΔrbpA::tet-rbpAMtb
WT strain transformed with pDB19-
rbpAMtb
WT was named csm291. Csm291 was transformed with pMSG430-rbpAMtb
R88A to replace 
the pDB19-rbpAMtb
WT construct at the attB site of csm291. Csm291 transformed with pMSG430-
rbpAMtb
R88A was named csm314. Genetic deletion of sigB was accomplished through engineering 
the conditionally replicating phage phAE87 and specialized transduction as previously described 
93,150. M. smegmatis ΔsigB was named csm375.  
Antibiotics and chemicals. In mycobacterial cultures, 20 μg/ml kanamycin, 12.5 μg/ml zeocin 
or 50 μg/ml hygromycin were used. In E. coli cultures, 40 μg/ml kanamycin, 50 μg/ml 
chloramphenicol, 50 μg/ml streptomycin, and 100 μg/ml ampicillin were used. 
RNA-seq analysis.M. smegmatis strains csm275, csm314, and csm375 were cultured to an 
OD600 of 0.4 to 0.6, pelleted, resuspended in TRIzol (Thermo Fisher Scientific), and lysed by 
bead beating (FastPrep; MP Bio, Santa Ana, CA). RNA was extracted with chloroform, 
precipitated with isopropanol, and resuspended in water. RNA was treated with DNase I 
(Thermo Fisher Scientific), and RNA integrity and quality were analyzed with an Agilent 
bioanalyzer. rRNA was removed from samples using the Illumina Ribo-Zero rRNA removal kit. 
cDNA libraries were generated using an adapted Illumina TruSeq library preparation kit and 
were quality controlled by analysis of the cDNA size distribution with the Agilent TapeStation. 
cDNA libraries were pooled and sequenced in a single lane of an Illumina HiSeq 2000 Rapid 
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Run flow cell with a 50-bp single-end read format. Sequencing reads were demultiplexed and 
converted to a FASTQ format using Illumina bcl2fastq script. Adapter sequences were trimmed 
from the raw reads, which were then aligned with the M. smegmatis mc2155 reference genome 
(GenBank accession number NC_008596) using the STAR aligner 116. Sequence alignment map 
(SAM) files generated from alignments were converted to BAM files using SAMTools 117, and 
aligned reads were counted per genome feature using the BioConductor package Subread 
featureCounts function 118. Differential expression analysis and subsequent PCA were performed 
with BioConductor DESeq2 119. Venn diagrams were made with an online tool 
(https://www.stefanjol.nl/venny). Hypergeometric P values and enrichment values were 
calculated using an online calculator (http://systems.crump.ucla.edu/hypergeometric). The 
hypergeometric distribution describes the probability of k successes in s draws, without 
replacement, from a population of size N that contains exactly M successes. N was defined at the 
total number of differentially expressed genes in the two RbpA mutant constructs being 
compared, s was defined as the number of differentially upregulated or downregulated genes in 
one RbpA mutant included in the comparison, M was defined as the number of differentially 
upregulated or downregulated genes in the second RbpA mutant included in the comparison, 
and k was defined as the number of differentially upregulated or downregulated genes shared by 
the two RbpA mutants in the comparison. 
Accession number(s). The data discussed in this publication have been deposited in the NCBI 







σB regulates transcription in a RbpA independent manner during logarithmic growth 
  RbpA interacts with the B bound holoenzyme but it is not clear whether all B regulated 
genes involve RbpA activity. To determine what portion of the B regulon is RbpA dependent 
we compared the transcriptomes of a M. smegmatis strain with a sigB deletion (ΔsigB) to a M. 
smegmatis strain expressing RbpAMtb
R88A, which weakens RbpA’s interaction with both σA and 
σB. If genes are differentially expressed in both strains, this suggests that these genes are 
regulated by the RbpA-σB complex. Genes that are differentially expressed in only M. smegmatis 
ΔsigB are genes that are regulated by σB in a RbpA independent manner. Genes that are 
differentially expressed in only the RbpAMtb
R88A strain are genes that are regulated by σA in a 
RbpA dependent and σB independent manner. 
 A total of 585 genes are differentially expressed in M. smegmatis ΔsigB based on a cut-
off of 2-fold increase or decrease in transcript levels compared to M. smegmatis with sigB intact 
(Figure 1a and 1b). Of the 585 genes, 149 genes were upregulated and 436 genes were 
downregulated. In M. smegmatis RbpAMtb
R88A there were a total of 233 genes differentially 
expressed, where 162 of the genes were upregulated and 71 genes were downregulated, 
indicating that RbpA’s interaction with σA and σB through R88 in most cases represses 
transcription but can also activate transcription at a smaller subset of genes. Among the total 304 
genes upregulated in either of the two strains there was only 7 genes that were upregulated in 
both strains (Figure 1a and 1b). Likewise, among the 491 genes downregulated in either strain, 
only 16 genes are downregulated in both strains. The minimal overlap in upregulated and 
downregulated genes in these two strains indicates that during logarithmic growth the σB regulon 
is regulated in a RbpA independent manner. 
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σB regulates small transcripts that if translated would encode short highly charged proteins 
 To better understand the role of σB during logarithmic growth in M. smegmatis we 
analyzed the most downregulated transcripts. Among the 30 most downregulated genes in M. 
smegmatis ΔsigB was a cohort of 20 genes that if translated encode small proteins (Figure 2). All 
20 of the genes encode for a protein that is less than 100 amino acids in length with an average 
length of 59 amino acids. Of the 20 genes that would be less than 100 amino acids long, 14 
would have an isoelectric point (pI) either below 4.0 or above 8.0. There is an even split between 
acidic and basic short proteins, with six proteins having a potential pI < 4.0 and eight proteins 
with a potential pI > 8.0.  
 Little is known about the function of the σB regulated M. smegmatis genes that potentially 
encode small proteins.  Most of the gene products do not have known orthologues in other 
bacterial species and of the 20 small gene products, 16 are annotated as hypothetical or 
conserved hypothetical in the mycobrowser database. The limited information available for these 
16 genes makes it unclear whether these transcripts are translated into short proteins or whether 
they function as small RNAs. In addition, the lack of orthologous genes suggests that whatever 
role(s) these gene products play is specific to M. smegmatis.  
Among the four genes that have annotation information available or a known ortholog in 
at least one additional mycobacteria species, are two genes, MSMEG_0360 and MSMEG_5635, 
which are annotated as conserved hypothetical but have orthologs in several other mycobacterial 
species. MSMEG_0360 is listed as an ortholog of M. tuberculosis Rv0236A that has been 
identified in whole cell lysate and is included in the ‘cell wall and cell processes’ functional 
category. A Rv0236A ortholog is found in other mycobacteria species including M. bovis, M. 
leprae and M. marinum. Though, MSMEG_0360 is likely translated, it is unclear whether 
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MSMEG_0360 is an essential protein in M. smegmatis due to the contradictory predictions of 
whether Rv0236A is essential in M. tuberculosis in two different transposon screens. 
MSMEG_0360 is not one of the 14 genes that potentially encode an acidic or basic protein, with 
a neutral pI of 6.6.  
M. tuberculosis Rv0909 is orthologous to MSMEG_5635 and orthologs are also found in 
M. bovis, M. leprae and M. marinum. The protein encoded by this gene has not been detected in 
whole cell lysate or filtrate and therefore it is unknown whether this gene is translated. Like 
MSMEG_0360, MSMEG_5635 is potentially a small protein but is not one of the highly charged 
σB regulated genes. MSMEG_5832 is annotated as phosphoribosylformylglycinamidine synthase 
(which may take the record for longest ‘product’ annotation on mycobrower…) and has been 
assigned the gene name purS. The M. tuberculosis, ortholog Rv0787A is predicted to be essential 
in M. tuberculosis and has been detected in whole cell lysate suggesting that MSMEG_5832 is 
likely translated in M. smegmatis. Like MSMEG_0360 and MSMEG_5635, if the 
MSMEG_5832 transcript is translated the protein is not highly charged. The annotation for 
MSMEG_0522 in mycobrowser lists pp24 protein as the gene product and the function of the 
protein is unknown. MSMEG_0522 does not have known orthologs in other mycobacterial 
species and if MSMEG_0522 is translated, the protein would be acidic with an isoelectric point 
of 3.62, however, there is no evidence that this transcript is translated. 
sigB is synthetically essential when RbpA activities are limited by point mutations in RbpA 
BL and SID 
 Our analysis of the sigB regulon during logarithmic growth indicated that RbpA 
dependent transcription mostly occurs through interactions with the RNAP-σA holoenzyme. To 
compare the roles played by RbpA BL versus RbpA SID during σA mediated transcription and 
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rule out any contribution made by interactions between RbpA and σB, we attempted to engineer 
M. smegmatis strains complemented with either rbpAMtb
R79A or rbpAMtb
R88A and sigB deleted. 
Three different approaches were taken to generate these strains without success (Figure 3). In 
the first approach, we attempted to swap rbpAMtb
R79A or rbpAMtb
R88A for the rbpAMtb
WT gene 
complemented at the phage attachment site, attB, in a strain of M. smegmatis lacking both the 
endogenous rbpA and sigB loci (Figure 3a). For a positive control, we transformed a plasmid 
carrying rbpAMtb
WT into M. smegmatis with rbpAMtb
WT complemented at the attB site (M. 
smegmatis rbpAMtb
WT). M. smegmatis colonies from these transformations were patched for 
selection on both zeocin, to select for colonies that likely retained zeocin linked rbpAMtb
WT at the 
attB site, and kanamycin to select for colonies that potentially replaced rbpAMtb
WT with a 
kanamycin linked mutant rbpA construct or rbpAMtb
WT in the case of the positive control. 
Transformations of rbpAMtb
R79A or rbpAMtb
R88A into M. smegmatis rbpAMtb
WT yielded far fewer 
colonies compared to the transformations of rbpAMtb
WT into either M. smegmatis ΔsigB 
rbpAMtb
WT or M. smegmatis rbpAMtb
WT as well as fewer colonies compared to transformations of 
rbpAMtb
R79A or rbpAMtb
R88A into M. smegmatis rbpAMtb
WT (Figure 3b). The few colonies that 
managed to survive the transformation of plasmids carrying rbpAMtb
R79A or rbpAMtb
R88A into M. 
smegmatis ΔsigB rbpAMtb
WT and initial selection on kanamycin were then patched for selection 
on zeocin and kanamycin to confirm the loss of zeocin resistance (ZeoR). A total of 79 colonies 
grew from the transformations of rbpAMtb
R79A into M. smegmatis ΔsigB rbpAMtb
WT and the initial 
selection on kanamycin. Of these 79 colonies, zero were kanamycin resistant and zeocin 
sensitive (KanR/ZeoS), and instead all were resistant to both antibiotics (KanR/ZeoR), indicating 
these colonies had not lost the rbpAMtb
WT gene at the attB site that occurs with loss of zeocin 
resistance. Likewise, only 58 colonies grew up from the transformation of rbpAMt 




WT and initial kanamycin selection. Patching of the 58 colonies on 
kanamycin and zeocin yielded 56 KanR/ZeoR colonies and two KanR/ZeoS. To determine whether 
the two colonies displaying the KanR/ZeoS phenotype had the rbpAMtb
WT or the mutant 
rbpAMtb
R88A allele, we sequenced the attB site and both KanR /ZeoS colonies had the rbpAMtb
WT 
gene rather than rbpAMtb
R88A indicating that through an unknown mechanism these two colonies 
had managed to acquire KanR without the replacement of rpbAMtb
WT with rbpAMtb
R88A. The 
inability to swap rbpAMtb
R79A or rbpAMtb
R88A for rbpAMtb
WT in M. smegmatis ΔsigB rbpAMtb
WT 





WT as well as the efficiency of swapping rbpAMtb
WT for rbpAMtb
WT in M. 
smegmatis ΔsigB rbpAMtb
WT. 
 The second approach to engineer M. smegmatis ΔsigB rbpAMtb
R79A or M. smegmatis ΔsigB 
rbpAMtb
R88A involved deleting the endogenous rbpA locus in a M. smegmatis strains lacking sigB 
and already complemented with either rbpAMtb
R79A or rbpAMtb
R88A at the attB site (Figure 3c). 
For this approach, we attempted to delete the endogenous rbpA locus using two step allelic 
exchange. This process includes an initial transformation of a plasmid containing a positive 
selection marker that confers M. smegmatis resistance to hygromycin (HygR) as well as two 
negative selection markers that confer M. smegmatis sensitivity to sucrose and 2-deoxygalactose 
(2-DOG). The transformants are first selected for hygromycin resistance indicating that the 
plasmid has recombined into the bacterial chromosome and these colonies are referred to as 
intermediates (Figure 3d). The plasmid that has recombined into the intermediate’s chromosome 
has sites of homology flanking rbpA that can recombine allowing the plasmid to remove itself 
from the chromosome. Sites of homology within the plasmid and bacterial chromosome are 
located such that recombination for plasmid removal can result in rbpA deletion or restoration of 
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the bacterial chromosome to the status prior to integration with equal probability for either 
outcome. Only the intermediates which underwent a second recombination event that removes 
the plasmid survive negative selection on agar containing sucrose and 2-DOG. The colonies 
capable of growing in the presence of sucrose and 2-DOG are then patched on LB-agar 
containing hygromycin and LB-agar containing both sucrose and 2-DOG to confirm the loss of 
HygR. The HygS /Suc 2-DOGR patches are rbpA deletion candidates. We determine whether the 
deletion candidates reverted to their original chromosome composition or lost rbpA during the 
second recombination event by southern blotting.  
The data collected from this second approach is limited but so far supports the hypothesis 
that sigB is made synthetically essential by the RbpA R79A and R88A substitutions. A technical 
hurdle of this approach is the low efficiency of the plasmid DNA recombination into the 
bacterial chromosome. So far only a total of five intermediates have grown from transformations 
into either M. smegmatis ΔsigB attB::rbpAMtb
R79A, M. smegmatis ΔsigB attB::rbpAMtb
R88A or M. 
smegmatis ΔsigB attB::rbpAMtb
WT and selection for HygR (Figure 3d). However, four of the 
intermediates originated from the transformation into M. smegmatis ΔsigB attB::rbpAMtb
R79A, 
which has yielded at least 26 deletion candidates. Another challenge of this approach is the lower 
throughput screening of the deletion candidates with southern blotting and therefore only six 
candidates have been screened so far. All six of the candidates had an intact rbpA endogenous 
locus. Although only six deletion candidates have been screened and more screening will be 
required to strengthen the conclusions drawn from this approach, the equal probability of the 
second recombination event yielding the original chromosome and deletion of rbpA means that 
we would have expected three of the six candidates to have lost rbpA during the second 
recombination event. Statistically, assuming that the outcome of the second recombination event 
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is binary and both possibilities are equally likely to occur then the probability that we would 
observe the same outcome for all six candidates is less than 2%. Moreover, among the six 
candidates screened for deletion of rbpA in M. smegmatis ΔsigB attB::rbpAMtb
WT, rbpA was 
deleted in two of the candidates, which is much closer to the expected 50% deletion rate that 
should occur when a gene is non-essential.  
 The third approach involved deleting sigB from M. smegmatis strains complemented with 
mutant rbpA constructs at the attB site and the endogenous rbpA locus deleted (Figure 3e). This 
approach utilizes a mycobacteria phage recombineered to target the M. smegmatis sigB locus and 
successful deletion of sigB occurs through a linear combination event that replaces the sigB locus 
with a hygromycin resistance cassette. Of the three approaches, I have collected the least amount 
of data for this approach and so far the data does not lend support either for or against the 
hypothesis that sigB is made synthetically essential by the RbpA substitutions R79A and R88A. 
Similar to the second approach, the screening of deletion candidates, in this case for the deletion 
of sigB, is done through low-throughput southern blotting. Only sigB deletion candidates that 
have come from the phage infection of the control M. smegmatis attB::rbpAMtb
WT have been 
screened. Zero out of six HygR M. smegmatis attB::rbpAMtb
WT sigB deletion candidates had a 
sigB deletion, probably indicating a problem with the phage recombineering and the need to 
troubleshoot the phage production.  
Discussion 
 The findings of this study shed new light on the role of sigB in M. smegmatis. We 
determine the sigB regulon and find that sigB regulates almost 1/10th of the M. smegmatis 
transcriptome during logarithmic growth in a mostly RbpA independent manner (Figure 1). We 
find that among the 30 genes most downregulated in the M. smegmatis sigB deletion strain are 
96 
 
genes that potentially encode functionally uncharacterized small proteins (Figure 2). Most of 
these genes do not have known orthologues in other bacterial species and if translated most of 
these proteins have extreme isoelectric points. In addition to determining that σB functions in a 
RbpA independent manner during logarithmic growth our data suggests that sigB is made 
synthetically essential by loss of RbpA activities that require RbpA BL and SID (Figure 3). 
 This data adds to the notion that the function of sigB in mycobacteria is distinct from that 
of rpoS in E. coli. In E. coli, σS and σ70 have distinct roles with σ70 controlling transcription 
during conditions permissive to fast growth and division while σS is thought to take control of 
transcription for survival in challenging environments. In mycobacteria, sigB is not only at levels 
comparable to sigA during logarithmic growth but now our data indicates σB serves an active role 
during logarithmic growth, contributing to the transcription of almost 600 genes.  Our 
observation that σB regulates many M. smegmatis genes during logarithmic growth aligns with 
the combined RNA-seq and ChIP-seq analysis of the M. tuberculosis σB regulon showing that σB 
regulates housekeeping genes during logarithmic growth 143. Another potential hint that σB is 
involved in housekeeping transcription comes from our finding that σB is synthetically essential 
when RbpA activities are limited. The reason why σB is conditionally essential is not yet clear 
but one possible explanation is σB’s contribution to housekeeping transcription becomes essential 
when limited RbpA activity results in diminished transcription of housekeeping genes. 
Collectively, this data suggests that mycobacteria σB is not only involved in responding to stress 
similar to the E. coli σS paradigm but is also contributing to fast growing mycobacteria 
transcription in a nutrient rich stress-free environment.  
Previously we showed that the R88A substitution weakens RbpA binding to both σA and 
σB, which would suggest that whatever the σB’s essential function is in the context of the RbpA 
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R88A mutation is RbpA independent 125. However, recent work characterizing the impact of 
substitutions targeting charged residues in RbpA BL found that the R79A substitution did not 
affect RbpA enhancement of σB activity, whereas other substitutions in RbpA including K73A 
and K74A weaken RbpA enhancement of σB activities 148. These results suggest that RbpA BL 
alters σA and σB activities through distinct mechanisms. In this case, perhaps the σB-RbpA R79A 
complex is still capable of carrying out functions that σA-RbpA R79A cannot. If σB-RbpA R79A 
is now responsible for an essential activity normally carried out by σA-RbpA then this could 
explain why deletion of σB is lethal in the R79A genetic context. 
Analysis of the 30 genes most downregulated in the M. smegmatis sigB deletion strain 
revealed that most of this cohort consists of small gene products encoding either short 
untranslated RNAs or small proteins with an average length of 59 amino acids. If these genes are 
translated, 16 of the 20 small proteins would be highly charged. For the most part, little is known 
about these 20 genes and the lack of known orthologues in other bacterial species suggests that 
they are unique to M. smegmatis.  
Molecular dissection of the E. coli σS regulatory network has shown that small regulatory 
RNAs are at the center of controlling σS levels and fine-tuning the general stress response to 
address a specific stress 136. In many cases, the small regulatory RNAs bind to the sigS transcript 
resulting in either stabilization or degradation of the sigS transcript. To my knowledge, it is 
unclear whether mycobacteria sigB is regulated post-transcriptionally through small RNAs. 
Future work that could provide insight into this question is determining whether the σB regulated 
small gene transcripts have stretches of complementary sequences that would base pair with the 
sigB transcript indicating that these small RNAs could bind and potentially regulate sigB post-
transcriptionally. In addition to binding the sigB transcript, the small genes could regulate sigB or 
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σB by binding to the transcripts of genes responsible for degrading the sigB transcript or σB 
proteolysis. 
 If future work determines that the σB regulated small genes are translated, then this opens 
the door to another set of interesting potential functions. Small highly charged proteins have 
been identified in many other bacterial species and have been found to serve numerous functions 
including but not limited to bacterial spore formation, stress signaling, efflux, cell division, 
quorum sensing, bacteriocin production that is utilized for bacterial chemical warfare and 
antibiotic resistance 151. The list of different types of small proteins and the functions they 
perform continues to expand providing many starting points for future work defining the 
















Figure 1. Overlap comparison of the upregulated and downregulated genes in M. smegmatis 
ΔsigB and M. smegmatis RbpAMtb
R88A. 
a. Venn diagram showing the number of the genes that are upregulated at least 2-fold in 
both M. smegmatis ΔsigB and M. smegmatis rbpAMtb
WT. 
b. Venn diagram showing the number of the genes that are downregulated at least 2-fold in 














Figure 2. List of the 30 most downregulated genes in M. smegmatis ΔsigB. Genes highlighted in 


























Figure 3. Genetic approaches used in the attempt to engineer M. smegmatis ΔsigB 
attB::rbpAMtb



































































The activities of all four RbpA structural domains are required for M. tuberculosis viability 
while only the RbpA BL and SID activities are sufficient for M. smegmatis viability but 
required for normal M. smegmatis growth 
To determine which of the four RbpA structural domains are essential for M. tuberculosis 
growth we engineered a cohort of RbpA mutants targeting each domain and tested whether the 
mutant RbpA constructs can support viability in either M. tuberculosis or M. smegmatis. The two 
RbpA truncation mutant constructs included in this analysis were RbpAMtb
1-71, which lacks both 
the C-terminal basic linker (BL) and sigma interaction domain (SID), and RbpAMtb
72-111, which is 
the inverse of RbpAMtb
1-71 and lacks the N-terminal tail (NTT) and core domain (CD). We found 
that neither RbpA truncation mutant supported M. tuberculosis viability while only RbpAMtb
72-111 
supported M. smegmatis viability suggesting that all four RbpA structural domains are required 
for M. tuberculosis viability while only the BL and SID domains are required for M. smegmatis 
viability (Chapter 2 Figure 1a)125. Prior work had shown that the R79 residue located in the 
RbpA BL is involved in RbpA’s interaction with DNA 22, while R88 located in RbpA’s SID is a 
key residue for M. tuberculosis RbpA binding to σA and σB 22. To determine whether RbpA BL 
and SID are essential in M. smegmatis and M. tuberculosis due to the activities mediated by R79 
and R88, we engineered the point mutant constructs RbpAMtb
R79A and RbpAMtb
R88A and tested 
whether RbpAMtb
R79A and RbpAMtb
R88A are viable in M. smegmatis and M. tuberculosis. Both 
RbpA point mutations are lethal in M. tuberculosis (Chapter 2 Figure 1a) 125. This result shows 
that RbpA activities mediated by R79 and R88 are at least one reason why the BL and SID are 
essential in M. tuberculosis. In M. smegmatis, both RbpA point mutations are viable but confer a 
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slow growth phenotype showing that R79 and R88 dependent RbpA activities are required for 
normal M. smegmatis growth (Chapter 2 Figure 1b and 1c)125. 
RbpA R88 is necessary and sufficient for RbpA binding to mycobacteria RNAP-σA and 
RNAP-σB holoenzyme 
RbpA makes several interactions with the RNAP-σA holoenzyme and is predicted to 
interact with the RNAP-σB holoenzyme in a similar fashion 22,67,106. To determine which RbpA 
structural domains are required for RbpA binding to the RNAP-σA and RNAP-σB holoenzymes 





72-111 and compared the levels of RNAP β subunit, as a 
read out for the core RNAP, σA and σB co-immunoprecipitated (co-IPed) by each RbpA 
construct. RbpAMtb
R79A-FLAG co-IPed similar levels of RNAP β, σA and σB indicating that the 
interactions mediated by RbpA R79 with either the RNAP-σA or RNAP-σB holoenzyme are not 
required for RbpA binding to either holoenzyme (Chapter 2 Figure 2a – 2c)125. RbpAMtb
R88A-
FLAG co-IPed almost undetectable levels of σA and σB, in agreement with previous data 
showing that the R88 equivalent in the S. coelicolor RbpA orthologue is required for RbpA 
binding to S. coelicolor’s principal housekeeping σ factor and principal-like alternative σ factor 
(Chapter 2 Figure 2a – 2c)110,125. In addition to σA and σB, RbpAMtb 
R88A-FLAG also co-IPed 
low levels of RNAP β that are comparable to the background amount RNAP β co-IPed by 
untagged RbpAMtb
WT (Chapter 2 Figure 2a and 2d)125. RbpA R88 is not positioned to interact 
with RNAP β or any of the other core RNAP subunits and is only positioned to interact with σA 
and σB 22,67,106. Based on the predicted lack of RbpA R88 interaction with other RNAP subunits 
and our finding that RbpAMtb
R88A co-IPed lower amounts of all the RNAP subunits we conclude 
that the RbpA R88 dependent interaction with σA or σB is necessary and sufficient for RbpA’s 
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interaction with the RNAP-σA and RNAP-σB holoenzymes. This assertion is strengthened by our 
additional finding that RbpAMtb
72-111-FLAG co-IPs the same level of RNAP β, σA and σB as 
RbpAMtb
WT-FLAG, showing that neither RbpA NTT or CD are required for RbpA binding to 
RNAP-σA or RNAP-σB holoenzymes (Chapter 2 Figure 2a – 2d)125. 
RbpA both promotes and antagonizes RNAP open promoter complex stability in a domain 
dependent manner 
An in vitro comparison of RNAP open promoter complex (RPo) stability between E. coli 
RNAP-σ70 holoenzyme and M. bovis RNAP-σA holoenzyme on the M. tuberculosis ribosomal 
rRNA AP3 (rrnAP3) promoter showed that E. coli RNAP-σ70 holoenzyme RPo stability is much 
higher compared to its M. bovis counterpart 115. Addition of M. tuberculosis essential RNAP 
binding protein CarD to the M. bovis RNAP-σA holoenzyme increased RPo stability. Likewise, 
RbpA increases RPo stability and together both CarD and RbpA increase M. bovis RNAP-σ
A RPo 
stability to a level higher than either factor individually and to a level that is comparable to E. 
coli RNAP-σ70 RPo
 65. To determine which RbpA domains increase RPo stability, we compared 





72-111. RbpA RPo stabilizing activity 
requires both R79 and R88, as a substitution at either residue results in complete loss of RbpA 
RPo stabilizing activity (Chapter 2 Figure 3a and 3b)
125. Conversely, the truncation of RbpA 
NTT and CD increased RbpA RPo stabilizing activity compared to RbpAMtb
WT showing that 
either RbpA NTT or CD or both domains antagonize M. tuberculosis RNAP-σA RPo stability. To 
further dissect which RbpA domain antagonizes RPo stability, we engineered RbpAMtb
26-111, 
which only lacks the RbpA NTT and measured M. tuberculosis RNAP-σA holoenzyme RPo 
stability when bound by RbpAMtb
26-111. The RPo stabilizing activity of RbpAMtb




WT but less than RbpAMtb
72-111 showing that both RbpA NTT and CD antagonize M. 
tuberculosis RNAP-σA RPo stabilizing activity (Chapter 2 Figure 3a and 3b)
125. 
RbpA BL and SID activities can repress and activate mycobacteria transcription in a gene 
dependent manner 
To determine which M. smegmatis genes are regulated by RbpA BL and SID dependent 




R88A. RNA was collected from the M. smegmatis strains grown to mid-
logarithmic phase and submitted for RNA-sequencing (RNA-seq). Both upregulated and 
downregulated genes were observed in both the RbpAMtb
R79A and RbpAMtb
R88A strains indicating 
that R79 and R88 dependent RbpA BL and SID activities in some cases activate transcription 
and in other cases repress transcription (Chapter 2 Figure 4b)125. Of the 103 genes significantly 
upregulated at least 2-fold in the M. smegmatis strain expressing RbpAMtb
R79A, 81 of these genes 
were also downregulated at least 2-fold in the M. smegmatis strain expressing RbpAMtb
R88A. 
Likewise, of the 96 genes downregulated at least 2-fold in the RbpAMtb
R79A expressing M. 
smegmatis, 34 of those genes were also downregulated at least 2-fold in RbpAMtb
R88A. The large 
degree of overlap in upregulated and downregulated genes between these strains shows that 
disrupted RbpA BL and SID activities results in a similar effect on transcription at various 
promoters across the M. smegmatis genome (Chapter 2 Figure 4c and 4d)125. 
Truncation of RbpA NTT and CD reduces RNA levels in M. smegmatis  
The RNA-seq results showed that a much larger cohort of genes is differentially 
expressed as a result of RbpA NTT and CD truncation compared to loss of R79 and R88 
dependent RbpA activities from M. smegmatis (Chapter 2 Figure 4b)125. The RNA-seq results 




different from those that are differentially expressed in either M. smegmatis expressing 
RbpAMtb
R79A or M. smegmatis expressing RbpAMtb
R88A. However, similar to the effect of RbpA 
BL or SID point mutations, the truncation of RbpA NTT and CD results in activation of some 
genes and repression of other genes (Chapter 2 Figure 4b)125. After completing the RNA-seq 
comparison, we recognized that one potentially important caveat of the RNA-seq experimental 
design is that equivalent μg amounts of RNA from each biological replicate were submitted for 
sequencing without considering how much total RNA was isolated from each biological 
replicate. Under this experiment design, a mutation or condition that increases or decreases the 
overall amount of RNA per bacterium would be masked. For example, if mutation A reduces the 
total amount of RNA per bacterium by one half compared to mutation B, we would submit RNA 
from 2X the number of bacterium with mutation A as that from mutation B in order to provide an 
equivalent μg amount of RNA for sequencing from each replicate. Most RNA-seq experiments 
compare changes in a transcriptome resulting from mutations or conditions that are not known to 
alter a cell’s transcriptional machinery and therefore this caveat is often not considered. 
However, because we know that RbpA is a part of the housekeeping transcription machinery in 
Actinobacteria we tested whether the point mutations in RbpA BL or RbpA SID or the 
truncation of both RbpA NTT and CD results in an overall increase or decrease in RNA per 
bacterium. We did this by ‘spiking-in’ a known μg amount of MS2 phage RNA into the total 
RNA collected where the amount of spike-in RNA added is determined by the number of 
bacteria that the RNA was collected from.  
Throughout the process of collecting RNA for RNA-sequencing I noticed that I was 
repeatedly extracting less RNA from M. smegmatis RbpAMtb
72-111 samples compared to samples 
from the other strains despite knowing that I was collecting RNA from an equivalent number of 
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bacteria based on the culture volume and OD600. Due to this observation, our spike-in analysis 
was guided by the suspicion that the amount of RNA per bacterium is lower in M. smegmatis 
RbpAMtb
72-111. When we used qRT-PCR and normalization to the MS2 spike-in control to 
measure the transcript levels of eight genes that are not differentially expressed in M. smegmatis 
RbpAMtb
72-111 according to the RNA-seq, we found that all eight genes were downregulated 
compared to M. smegmatis RbpAMtb
WT (Chapter 2 Figure 4e)125. To further investigate this 
discrepancy between the RNA-seq and qRT-PCR spike-in control results, we then analyzed the 
transcript levels of the eight most upregulated genes in M. smegmatis RbpAMtb
72-111 according to 
the RNA-seq and found that these genes are also downregulated compared to M. smegmatis 
RbpAMtb
WT. The downregulation of all 16 genes evaluated by qRT-PCR, provides strong 
evidence in support of our hypothesis that the truncation of RbpA NTT and CD results in overall 
decrease in transcription  
When we measured the transcript levels of these same 16 genes in M. smegmatis 
RbpAMtb
R79A and M. smegmatis RbpAMtb
R88A using the qRT-PCR spike in control method, the 
results from the RNA-seq and qRT-PCR spike in control agreed (Chapter 2 Figure 4e)125. In 
this case, the agreement between the two techniques provided confirmation of the RNA-seq 
results and supported the conclusion that the loss of R79 and R88 dependent RbpA BL and SID 
activities does not reduce overall levels of RNA per bacterium. 
RbpA R10 and RbpA E17 synergize to promote fidaxomcin inhibition of M. tuberculosis 
RNAP-σA activity in vitro while other conserved RbpA NTT residues including R4, L6, R7 
and S15, RbpA CD, RbpA R79 and RbpA R88 do not 
 Fidaxomicin (Fdx) inhibits M. tuberculosis RNAP-σA activity in vitro and M. smegmatis 
growth in a RbpA NTT dependent manner 67. The structure of Fdx bound to M. tuberculosis 
111 
 
RNAP-σA in complex with RbpA shows that RbpA NTT is positioned near the Fdx binding 
pocket and RbpA NTT residues R10 and E17 interact with Fdx 67. Based on these data, Boyaci et 
al. hypothesized that RbpA NTT dependent Fdx activity is due to RbpA NTT’s contribution to 
the binding interface between Fdx and M. tuberculosis RNAP-σA. To further interrogate the 
mechanism of RbpA NTT dependent Fdx activity and test whether RbpA R10 and E17 increase 
Fdx activity we measured the in vitro Fdx activity against M. tuberculosis RNAP-σA bound by 




the alanine substitution of RbpA R10 and E17 did not change Fdx activity against the M. 
tuberculosis RNAP-σA  holoenzyme when compared to Fdx activity against RbpAMtb
WT bound M. 
tuberculosis RNAP-σA (Chapter 3 Figure 1a and 1b). However, alanine substitutions of both 
R10 and E17 occurring in the double point mutant RbpAMtb
R10A/E17A construct, decreased Fdx 
activity against M. tuberculosis RNAP-σA by approximately three-fold. These findings show that 
RbpA NTT dependent activity against the M. tuberculosis RNAP-σA is partially due to 
combination of RbpA R10 and E17 but that additional RbpA NTT residues are involved in Fdx 
inhibition of M. tuberculosis RNAP-σA activity. 
To identify other RbpA NTT residues that play a role in RbpA NTT dependent Fdx 
inhibition of M. tuberculosis RNAP-σA activity we engineered a cohort of mutant RbpA 
constructs targeting four of the most highly conserved RbpA NTT residues, including R4, L6, R7 
and S15 106. When we measured Fdx inhibition of the M. tuberculosis RNAP-σA holoenzyme in 







S15A we observed the same level of Fdx inhibition of RbpAMtb
WT bound M. tuberculosis 
RNAP-σA activity, suggesting that R4, L6, R7 and S15 are not individually required for RbpA 
NTT dependent Fdx activity (Chapter 3 Figure 3c and 3d).  
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To investigate whether the activities of RbpA structural domains besides the NTT affect 




R88A bound M. tuberculosis RNAP-σA. In the presence of 
RbpAMtb
R79A or RbpAMtb
R88A, Fdx inhibition of the M. tuberculosis RNAP-σA holoenzyme was 
the same as in the presence of RbpAMtb
WT showing that R79 dependent BL activities, R88 
dependent SID activities do not contribute to Fdx inhibition of M. tuberculosis RNAP-σA 
activity. RbpAMtb
72-111 and RbpAMtb
26-111 permit similar levels of Fdx inhibition indicating that 
the CD does not affect Fdx inhibition of M. tuberculosis RNAP-σA activity in vitro (Chapter 3 
Figure 3e). 
Multiple RbpA domains and CarD impact fidaxomicin inhibition of M. smegmatis growth 
 Our in vitro analysis of Fdx inhibition of M. tuberculosis RNAP-σA activity showed that 
only the truncation of RbpA NTT or alanine substitution of both R10 and E17 decrease Fdx 
activity (Chapter 3 Figure 1a and 1b). Based on these results we predicted that Fdx would be 
equally lethal against M. smegmatis expressing RbpAMtb
WT and the rest of the M. smegmatis 
strains expressing the mutant RbpA constructs we interrogated in vitro, with the exception of M. 
smegmatis strains expressing either RbpAMtb
26-111, RbpAMtb
72-111 or RbpAMtb
R10A/E17A that we 
expected to be less sensitive to Fdx. Contrary to our expectations, several M. smegmatis strains 
expressing various mutant RbpA constructs showed either an increase or decrease in sensitivity 
to Fdx compared to M. smegmatis RbpAMtb
WT (Chapter 3 Figure 3). Among the strains 
expressing RbpA NTT point mutants, RbpAMtb
R4A and RbpAMtb
R7A were more sensitive to Fdx at 
each concentration included in the analysis. At lower Fdx concentrations, M. smegmatis 
RbpAMtb
R4E was less sensitive to Fdx. Also contrary to our predictions based on the in vitro 
results was the finding that M. smegmatis RbpAMtb




equally sensitive to Fdx. Strikingly, M. smegmatis RbpAMtb
R79A and RbpAMtb
R88A were 
significantly more sensitive to Fdx treatment. These in vivo results show that RbpA impacts Fdx 
inhibition of M. smegmatis growth in a way that is not recapitulated in the in vitro assay.  
 The observation that RbpA residues which are not predicted to directly interact with Fdx 
can alter M. smegmatis sensitivity to Fdx led us to investigate whether CarD, which is also not 
predicted to interact with Fdx, affects M. smegmatis sensitivity to Fdx. A glutamate substitution 
at CarD R25 in CarD’s RNAP interaction domain weakens CarD binding to the RNAP β subunit 
and results in dysregulated transcription at over half of M. tuberculosis’s genes 94,97,99. We 
compared M. smegmatis CarDMtb
R25E and M. smegmatis CarDMtb
WT sensitivity to Fdx and found 
that loss of R25 dependent CarD activity significantly increases M. smegmatis sensitivity to Fdx 
(Chapter 3 Figure 3d and 3e). This result shows that M. smegmatis sensitivity to Fdx occurs 
through both RbpA dependent and independent mechanisms. 
RbpA NTT residues positioned near the RNAP β’ lid, RNAP σA region 3.2, and RNAP β’ 
ZBD antagonize RbpA RPo stabilizing activity 
 We showed that RbpA NTT antagonizes RbpA RPo stabilizing activity through an 
unknown mechanism (Chapter 2 Figure 3)125. To gain insight into this mechanism, we 
investigated how RbpA NTT residues positioned near different regions of the RNAP contribute 
to RbpA NTT antagonism of RNAP-σA RPo stability. We determine that alanine substitution of 
L6, positioned near hydrophobic residues in the RNAP β’ lid, RNAP β Sw3 and RNAP σA 
region 3.2 and R7 increase RbpA RPo stabilizing activity (Chapter 3 Figure 4a and 4b). In 
addition, alanine substitutions at RbpA S15 and E17 positioned near the RNAP β’ zinc binding 
domain also increase RbpA RPo stabilizing activity. These results suggest that RbpA NTT 
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antagonism of RPo stability could occur through RbpA NTT interactions with RNAP β’ lid, 
RNAP β Sw3, RNAP σA region 3.2, and RNAP β’ ZBD. 
RbpA NTT promotes full-length transcription 
 It is unknown why the amount of RNA per cell is decreased in M. smegmatis RbpAMtb
72-
111 (Chapter 2 Figure 4e). One possible explanation is that the truncation of RbpA NTT and CD 
antagonizes full-length transcription. To begin dissecting whether RbpA NTT promotes full-
length transcription, we compared M. tuberculosis RNAP-σA activity on the M. tuberculosis 
rrnAP3 promoter in the presence of RbpAMtb
WT to that in the presence of RbpAMtb
26-111. Similar 
to previous reports, we found that RbpAMtb
WT increases full-length transcription from rrnAP3 
(Chapter 3 Figure 5)108. In contrast, full-length transcription in the presence of RbpAMtb
26-111 
was attenuated compared to in the presence of RbpAMtb
WT, showing that RbpA NTT facilitates 
full-length transcription. 
During logarithmic growth, σB regulates approximately 10 percent of M. smegmatis genes 
in a mostly RbpA independent manner 
 To better understand the role of σB in M. smegmatis, we deleted sigB and compared the 
transcriptomes of M. smegmatis ΔsigB and M. smegmatis with sigB intact during mid-
logarithmic growth with RNA-seq. A total of 585 genes were significantly upregulated or 
downregulated at least 2-fold in M. smegmatis ΔsigB (Chapter 4 Figure 1). Among these 585 
genes, 420 were downregulated at least 2-fold indicating that σB contributes to M. smegmatis 
transcription during logarithmic growth mostly through activating transcription. RbpA interacts 
with both σA and σB but it is unclear how RbpA impacts the function of σA and σB in vivo 107,108. 
To better understand the extent to which σB regulated transcription requires interaction with 




The R88A substitution in RbpA SID weakens RbpA’s interaction with both σA and σB and 
therefore this comparison between M. smegmatis ΔsigB and M. smegmatis RbpAMtb
R88A allows 
us to identify which genes are regulated by σB in a RbpA independent manner and which genes 
are regulated in a RbpA dependent manner (Chapter 2 Figure 2)125. Specifically, genes that are 
differentially expressed only in M. smegmatis ΔsigB are interpreted as genes that are σB regulated 
in a RbpA independent manner and genes that differentially expressed in both strains are 
considered genes that are σB regulated in a RbpA dependent manner. Of the 585 differentially 
expressed genes in M. smegmatis ΔsigB only 23 are also differentially expressed in M. 
smegmatis RbpAMtb
R88A in the same direction indicating that transcription of the σB regulon 
occurs in a mostly RbpA independent fashion (Chapter 4 Figure 1). 
20 of the 30 most downregulated genes in M. smegmatis encode small gene products 
 Most of the differentially expressed genes in M. smegmatis ΔsigB are downregulated and 
among the most downregulated genes is a group of small genes (Chapter 4 Figure 2). Little is 
known about the function of the small genes including whether or not they encode small non-
translated RNAs or small proteins. If these σB regulated genes are translated, 16 of the 20 would 
be highly acidic or basic with an isoelectric point less than 4 or greater than 8. Most of the genes 
do not have known orthologues in other bacterial species suggesting that the proteins are M. 
smegmatis specific or comprise one or more novel classes of proteins. 
M. smegmatis sigB is made synthetically essential by point mutations in RbpA BL and SID 
 Experiments that were designed to differentiate the functions of RbpA bound σA and 
RbpA bound σB  required engineering M. smegmatis ΔsigB strains with point mutations in RbpA 
BL and SID. So far, we have used three different approaches using a variety of genetic tools to 
try and obtain either of these two M. smegmatis strains and have been unsuccessful (Chapter 4 
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Figure 3). The inability to engineer these strains through various approaches supports the 
conclusion that sigB is synthetically essential when RbpA BL and SID activities are limited. 
Open questions 
How do other bacterial RNAPs carry out whatever essential function(s) RbpA performs in 
mycobacteria? 
 RbpA is only conserved within the Actinobacteria phylum, which raises the question of 
how RNAPs from other bacterial phyla accomplish the tasks performed by RbpA. Some insight 
into this question has been gained through the comparison of the M. tuberculosis RNAP-σA 
holoenzyme and the E. coli RNAP-σ70 holoenzyme in vitro RPo stability 
64,65. This comparison 
showed that RbpA increases M. tuberculosis RNAP-σA holoenzyme RPo stability and that RbpA 
is required for the M. tuberculosis RNAP-σA holoenzyme to reach the same level of RPo 
stabilization achieved by the E. coli RNAP-σ70 65. This comparison also indicates that E. coli’s 
housekeeping holoenzyme has one or more RPo stabilizing features that the M. tuberculosis 
RNAP-σA holoenzyme does not have. Characterization of the E. coli RNAP-σ70 holoenzyme has 
identified structural regions involved in RPo stabilization and one of these RPo stabilizing 
structural regions is a lineage specific insertion unique to γ-Proteobacteria called the β’ sequence 
insertion 3 (β’ SI3)5. The similar effect that RbpA and β’ SI3 have on increasing RPo 
stabilization lends itself to the possibility that RbpA is essential because the M. tuberculosis 
RNAP-σA holoenzyme does not have the β’ SI3 and Actinobacteria have evolved an alternative 
RbpA dependent solution for stabilizing RPo. However, even if this turns out to be true the 
exclusivity of RbpA among Actinobacteria and β’ SI3 among γ-proteobacteria indicates that 
there are still additional RPo stabilizing mechanisms among the bacterial phyla that lack both 
RbpA and β’ SI3. 
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 RbpA might also be essential for a different reason. One strategy that could potentially 
shed light on RbpA’s essential function is to further explore the functions of bacterial RNAP 
lineage specific insertions such as the γ-Proteobacteria β’ SI3 that connect conserved regions of 
the RNAP 6,7. There are a limited number of lineage specific insertions, and one could engineer a 
cohort of M. tuberculosis strains where each strain has a M. tuberculosis RNAP-σA holoenzyme 
containing one lineage specific insertion. One could then attempt to delete RbpA from these 
strains (if these M. tuberculosis RNAP-σA holoenzyme containing lineage specific insertions are 
viable) to identify which lineage specific insertions are functionally linked to RbpA. 
 RbpA could also be essential due to the presence rather than absence of a M. tuberculosis 
RNAP-σA holoenzyme feature. Some of these features are discussed in the chapter 1 
introduction, including the Actinobacteria lineage specific RNAP β’ insertion, the N-terminal 
extension attached to σA region 1.1 and the other essential RNAP binding protein CarD. To my 
knowledge it is unknown whether the Actinobacteria lineage specific RNAP β’ insertion or σA 
region 1.1 tail are essential in mycobacteria. If these features are not essential one could engineer 
M. tuberculosis strains lacking these structures and then try deleting rbpA to test whether RbpA 
is required because of these structures. CarD is essential and therefore more advanced genetic 
approaches would be required to test the hypothesis that RbpA is essential because of the 
existence of CarD. However, a potential starting point could be attempting to delete rbpA in M. 
tuberculosis strains encoding CarD point mutations, such the R25E and K125A that limit 
different CarD functions 94. 
 Comparisons of M. tuberculosis and E. coli promoters show that M. tuberculosis 
promoter architecture is less stringently defined compared to E. coli 10,90. The prevalence of 
multiple promoter sequence elements such as the -35 element and UP element is lower in M. 
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tuberculosis promoters and there is more flexibility in nucleotide identity within M. tuberculosis 
promoter sequence elements such as the -10 element where the consensus sequence is defined as 
5’ – TANNNT – 3’ compared to 5’ – TATAAT – 3’ in E. coli 10,90. These comparisons raise the 
question of what mechanisms might compensate for the lack of promoter architecture in M. 
tuberculosis. One hypothesis is that M. tuberculosis requires less promoter sequence stringency 
because RNAP binding factors like RbpA perform the functions carried out by a particular 
sequence element in E. coli. This hypothesis is supported by data showing that the activity of the 
M. tuberculosis RNAP-σA holoenzyme at a promoter can be increased by either RbpA or the 
addition of an extended -10 element to the promoter, suggesting there is functional overlap 
between the extended -10 element and RbpA 148,152. 
 Studies defining the consensus promoter sequence elements in M. tuberculosis have for 
the most part focused on the promoter sequence elements that are important in E. coli. Though 
informative, these analyses potentially miss promoter sequence elements found in M. 
tuberculosis that are absent in E. coli. Furthermore, RbpA could be utilizing an undiscovered 
promoter sequence element. Future chromatin immunoprecipitation sequencing (ChIP-seq) 
experiments that determine which promoters RbpA localizes to in conjunction with our RNA-
sequencing experiments will more clearly define the RbpA regulon and allow us to evaluate 
whether there is a RbpA specific promoter architecture and if so, what sequence elements 
constitute this architecture. 
Why does RbpA bind both σA and σB? 
 Structural characterization of RbpA binding to the M. tuberculosis RNAP-σA holoenzyme 
has revealed which RbpA residues interact with which σA residues 22,67,106. A comparison of σA 
and σB amino acid sequences shows that the σA residues involved in the interaction with RbpA 
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are mostly conserved in σB but not conserved in the other M. tuberculosis σ factors 22. Despite 
knowing how RbpA interacts with σA and σB, there are still many open questions centered 
around when and why RbpA interacts with each σ factor. For instance, we do not know how 
much RbpA bound or unbound σA or σB exists in the bacterium and we do not know the amount 
of functional overlap, if any, between σA, σB, RbpA bound σA and RbpA bound σB. 
 We have made some progress in understanding the roles of RbpA bound or unbound σA 
and σB. Our co-IP experiments (Chapter 2 Figure 2) show that RbpA is bound to both σA and 
σB during M. smegmatis logarithmic growth and that RbpA’s interaction with at least one of the 
two σ factors is in the context of the RNAP due to RbpA’s interaction with σ being required for 
RbpA co-IP of core RNAP 125. However, these experiments did not determine how much of the 
total cellular σA or σB is bound to RbpA and whether RbpA interacts with both σA and σB in the 
context of the RNAP. One way to address this question in future work would be to compare the 
levels of RbpA and core RNAP co-IPed by σA and σB.  
Another experiment that has shed some light on RbpA bound versus unbound σA and σB 
functions is our RNA-seq analysis of the M. smegmatis σB regulon during logarithmic growth. 
The results suggest that σB contributes to transcription during logarithmic growth along with 
RbpA bound or unbound σA. A comparison of the transcriptomes from M. smegmatis ΔsigB and 
M. smegmatis RbpAMtb
R88A shows that σB regulation during logarithmic growth occurs in a RbpA 
independent manner based on the lack of overlap in genes that are differentially expressed when 
σB is lost and when σB interaction with RbpA is weakened (Chapter 4 Figure 1). To better 
define RbpA dependent and independent σA and σ
B functions in the future we have begun the 
process of engineering two M. smegmatis strains that have a point mutation in either σA or σB at a 




mutants are viable and weaken σA or σB interaction with RbpA without impacting any other σA 
or σB activities, these strains could prove useful in separating out RbpA bound and unbound σA 
and σB functions.  
Why is sigA essential and sigB non-essential in mycobacteria? 
 SigA encodes the essential principal housekeeping σ factor while sigB encodes the non-
essential principal-like σ factor. In vitro analysis of M. tuberculosis RNAP-σA holoenzyme and 
M. tuberculosis RNAP-σB holoenzyme has shown that at the M. tuberculosis housekeeping 
rrnAP3 promoter, the activity of RNAP-σA holoenzyme is greater than that of RNAP-σB 
holoenzyme providing an explanation as to why sigA is essential and sigB is not (Drake Jensen 
and Eric Galburt, unpublished data). However, to my knowledge it is not clear why σA promotes 
higher M. tuberculosis holoenzyme activity compared to σB. Overall the structure of σA and σB 
are similar with the exception of the long σA region 1.1 N-terminal tail extension. The enigmatic 
structure and function of the σA region 1.1 N-terminal extension have eluded characterization but 
is likely to at least in part explain why sigA is essential. We have begun the process of 
engineering a M. tuberculosis sigA construct lacking the region 1.1 N-terminal extension and 
plan to also engineer a M. tuberculosis sigB construct with the σA region 1.1 N-terminal 
extension to address whether this structural region underpins sigA’s status as an essential σ 
factor.  
What are the determinants of RbpA transcriptional activation versus repression? 
 RNA-seq analysis of M. smegmatis RbpA mutants suggests that RbpA activates 
transcription at some promoters and represses transcription at other promoters (Chapter 2 
Figure 4). A thermodynamics based model for how a factor can both activate and repress 
transcription has been developed by Eric Galburt’s lab, which hypothesizes that transcriptional 
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flux is a function of basal rate constants during transcription initiation that vary among promoters 
135. Moreover, depending on the basal rate constants of a given promoter, which rate constants a 
factor such as RbpA affects and how much the factor changes the basal rate constants, the 
transcriptional flux can be either increased or decreased by a factor which results in either 
activation or repression of transcription. The Galburt lab and our lab have together determined 
that RbpA affects rate constants of promoter melting and promoter escape during transcription 
initiation on the M. tuberculosis rrnAP3 promoter (Chapter 2, Figure 3)65,69,125. Based on these 
findings, we know that the basal rate constants of promoter melting and promoter escape are 
determinants of whether RbpA activates or represses transcription. However, we have much to 
learn about what determines the basal rate constants of promoter melting and promoter escape 
for M. tuberculosis promoters with many factors to consider such as promoter sequence 
elements, the presence or absence of other factors such as CarD and chromosomal architecture. 
This question is further complicated by RbpA’s four structural domains each having its own 
effect on promoter melting and promoter escape as indicated by the finding that RbpA NTT and 
CD antagonize RPo stability, while the BL and SID are required for RbpA’s RPo stabilizing 
activity (Chapter 2 Figure 3)125. Lastly, we have not yet fully explored whether RbpA has 
additional functions that could impact transcriptional flux via transcription initiation or one of 
the other steps required for full-length transcription. 
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